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Abstract  
Intramuscular triglycerides (IMTG) are stored in lipid droplets (LD) in skeletal muscle, and it is 
thought that subcellular location, size and number of LDs relate to insulin sensitivity (IS) more 
so than IMTG content alone. Reduced expression and function of mitochondria has been 
implicated in the development of insulin resistance, leading to an accumulation of IMTG due 
to reduced oxidative capacity. The aim of the present study was to 1) establish a better 
understanding of the sex differences in the relationship between LD profile, mitochondrial 
density and the development of insulin resistance thereby 2) contributing to current and future 
research improving insulin sensitivity and preventing the progression of insulin resistance. The 
study investigated the hypothesis that 1) females have greater LD stores compared to males 
whilst maintaining insulin sensitivity, and 2) that type two diabetes (T2D) patients have greater 
LD stores compared to their lean and obese counterparts. Muscle biopsies were obtained from 
48 male (n=24) and female (n=24) participants, categorised into groups (n=16/group) based 
on metabolic health; lean, obese and T2D. Cryosections (5μm) were stained using appropriate 
antibodies targeting myosin heavy chain I (MHC I) and MHC IIa. LDs were stained using bodipy 
493/503 and mitochondria using mouse monoclonal anti-OxPhos complex IV (COXIV).  Images 
were obtained using widefield and confocal fluorescence microscopy. In males, LD content was 
two-fold greater (P<0.05) within both the central and peripheral (5μm below cell membrane) 
regions of the type I and II fibres due to a two-fold increase in LD density (P<0.05) alongside 
larger LDs by one-fold (P<0.05) in comparison to females; thereby contradicting the first 
hypothesis. However, in agreement with the second hypothesis LD content was two-fold 
greater (P<0.05) in male T2D specifically within the central region of the type IIa fibres 
compared to the lean and obese males; primarily driven through larger LDs by one-fold 
(P<0.05). Furthermore, mitochondrial density followed a hierarchical distribution (TI>TII; 
P<0.001) in both males and females, with no differences observed between sexes or metabolic 
health status (P>0.05). In conclusion, this thesis presents novel data on sex differences in LD 
profile, mitochondrial density and insulin resistance and suggests a potential sex paradox; 
whereby reduced sex hormone production in post-menopausal females, alongside inactivity 
maybe more important determinants of insulin sensitivity than LD profile alone. 
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1. Introduction  
1.1 Obesity epidemic and the prevalence of type 2 diabetes   
The current obesity epidemic and prevalence of type 2 diabetes (T2D) suggests that attempts 
to prevent these conditions thus far have not been effective. On a global scale, the prevalence 
of obesity continues to rise with 650 million adults worldwide now classified as obese (BMI ≥ 
30 kg.m-2) (World Health Organisation, 2017). In 2017 the percentage of adults in the UK 
classified as obese increased to 27%, which is an 11% increase since 1993. Data suggest that 
25% of the adult population are classified as sedentary, meaning that they fail to achieve the 
recommended 150 minutes of moderate-intensity aerobic physical activity (PA) per week 
(Sport England, 2019). Physical inactivity has major implications for health and for the 
prevalence of non-communicable diseases and their risk factors, which include elevated blood 
pressure, decreased insulin sensitivity and obesity (Blair, 2009; Lee et al., 2012). Furthermore, 
physical inactivity can be associated with poor mental health and a reduced quality of life 
(Wardoku et al., 2019). According to Public Health England (2017) physical inactivity is severely 
impacting the national economy costing the wider society £27 billion per annum, and the UK-
wide NHS costs are estimated to reach £9.7 billion per annum by 2050. Furthermore, as the 
fourth leading risk factor for global mortality (World Health Organisation, 2017), it is crucial 
that research surrounding physical inactivity and the subsequent development of insulin 
resistance is prioritised. More specifically the highest priority should be given to establishing a 
better understanding of the mechanisms by which physical inactivity and obesity leads to 
metabolic and (cardio)vascular diseases and how risks may be reduced with the identification 
of these key mechanisms.  
Metabolic syndrome (prediabetes) and T2D are the fastest growing metabolic diseases related 
to inactivity and obesity, not only within the UK, but also worldwide (Pedersen, 2006). Recent 
analyses by Diabetes UK has revealed that the number of individuals diagnosed with T2D in the 
UK has more than doubled within the last twenty years, and the total number is expected to 
surpass five million by 2025, with a greater prevalence reported in men compared to women 
(Wild et al., 2004). The number of people diagnosed with diabetes has more than doubled 
since 1998; currently ~3.8 million UK citizens have diabetes. When considering the 
undiagnosed population in the UK the estimate rises to 4.7 million (Diabetes UK, 2019). 
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Furthermore, T2D accounts for approximately 90% of all diabetes cases in the UK with an 
estimated 12.3 million people at an increased risk of developing T2D.  
Currently, obesity is the leading risk factor in the development of T2D (Abdullah et al., 2010). 
T2D is characterised by insulin resistance, which describes an insufficiency of the body’s organs 
and tissues to respond effectively to physiological increases in circulating insulin. Insulin is a 
key hormone produced by the pancreas regulating the uptake of glucose into tissues around 
the body (Wilcox, 2005). Insulin contributes to the regulation of blood glucose concentrations. 
Therefore a blunted response to insulin results in elevated blood glucose concentrations 
(hyperglycaemia) for prolonged periods following a meal (Hayward et al., 2015). Severe 
cardiovascular and microvascular complications are consequences of uncontrolled blood 
glucose concentrations, which ultimately increases the risk of premature mortality (Watkins et 
al., 2003). The consumption of a Western diet, which is typically energy dense and rich in fat, 
results in impaired buffering capabilities of adipose tissue implying that part of the meal lipid 
intake will be deposited into other metabolic tissues, such as skeletal muscle and the liver, with 
this lipid spill-over contributing to the development of insulin resistance and T2D (see 5.1.2) 
(Frayn, 2002b). Reduced triacylglycerol (TAG) clearance in adipose tissue due to impaired 
buffering capacity results in high plasma TAG concentration and the accumulation of TAG in 
insulin-responsive tissues, which then develop insulin resistance. Furthermore, impaired 
insulin action compromises the ability of insulin to suppress free fatty acid (FA) release from 
adipose tissue (Frayn, 2002a). Normal buffering action of adipose tissue would increase TAG 
clearance which in turn suppresses the release of non-esterified FAs into the circulation. 
However, in obese and insulin resistant individuals, adipose tissue buffering of lipid fluxes 
following a meal is impaired due to the incapacity of adipose tissue to respond appropriately 
to the high plasma glucose, FA and TAG concentrations  which occur post meal ingestion 
(Frayn, 2002a). The accumulation of lipid in skeletal muscle has been proposed to be a 
contributing factor for insulin resistance (Samuel, Petersen and Shulman, 2010; Turner et al., 
2014; Kitessa and Abeywardena, 2016), and therefore it is essential that research provides 
further insight into the potential mechanisms by which impaired or abnormal lipid storage may 
cause insulin resistance. Such research could support the development of progressive 
pharmacological and non-pharmacological methods which may be used to reduce the risk of 
T2D.   
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1.2 Skeletal Muscle Insulin Sensitivity  
Skeletal muscle is the primary tissue for glucose disposal from the circulation and accounts for 
an estimated 65-70% of whole-body insulin-mediated glucose uptake during a 
hyperinsulinaemic euglycaemic clamp (DeFronzo et al., 1981). Glucose uptake into muscle is 
fundamentally insulin dependent via the translocation of glucose transporter 4 (GLUT4) 
(Wilcox, 2005). Preservation of skeletal muscle mass and function throughout life preserves 
physical independence in older age whilst also protecting individuals from a multitude of 
metabolic diseases which include insulin resistance (Brook et al., 2016). Periods of 
immobilization due to major surgery and hospitalisation often result in muscle atrophy, 
especially within older individuals who fail to regain sufficient levels of physical activity thereby 
negatively impacting muscle health and function resulting in impaired insulin action (Knudsen 
et al., 2012). Indeed, prolonged sedentary behaviour may contribute to compromised mobility 
and associated reductions in quality of life (Brook et al., 2016). Skeletal muscle insulin 
sensitivity may be positively or negatively influenced by a respective increase or decrease in 
physical activity alongside other factors (e.g. diet) due to its high plasticity to adapt or mal-
adapt (Hoppeler, 2016). Maintaining skeletal muscle insulin sensitivity is paramount in the 
prevention and management of T2D amongst other metabolic defects  (DeFronzo and Tripathy, 
2009). 
1.2.1 Overview of Insulin action  
Under post absorptive (fasted) conditions insulin levels are characteristically low with higher 
concentrations present in the fed state. Blood glucose concentrations within healthy 
individuals will increase 30-40 minutes following glucose consumption during a 75g oral 
glucose tolerance test (OGTT) and would be expected to return to near baseline levels (<5.5 
mmol.L-1) 2 h into the OGTT (Wilcox, 2005). Research from Diabetes UK suggest that individuals 
with T2D have a fasting blood glucose concentration above 7 mmol.L-1, with an inability to 
reduce blood glucose concentration below 11.1 mmol.L-1 2 h into the 75g OGTT (Diabetes, 
2015). A rise in plasma glucose concentrations induced by meal-ingestion stimulates an 
increase in insulin secretion from the pancreas. Normal fasting plasma glucose (euglycaemia) 
concentrations are maintained through an enhanced activity of tissue-specific glucose 
transporters within skeletal muscle, liver and adipose tissue in response to physiological 
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increases in insulin thus facilitating the removal of glucose from the circulation(Wilcox, 2005). 
Glucose can be stored as liver and muscle glycogen or utilised as a source of energy within the 
skeletal muscle through the glycolytic pathway and complete aerobic oxidation to CO2 and 
H2O. Consumption of high carbohydrate diets may also lead to lipogenesis (conversion of 
glucose to FA and TAG synthesis) in adipose tissue cell.  
1.2.2 Insulin-meditated glucose uptake into skeletal muscle  
The process which activates the insulin signalling cascade in skeletal muscle commences when 
insulin binds to the extracellular α-subunit of the insulin receptor, thus stimulating tyrosine 
auto-phosphorylation of the transmembrane β-subunit (Pessin and Saltiel, 2000). This cascade 
of events activates the intrinsic tyrosine kinase resulting in tyrosine phosphorylation of the 
insulin receptor substrate (IRS) proteins (Pessin and Saltiel, 2000). Activation of the insulin 
receptor results in the activation of two imperative signalling cascades; the mitogen-activated 
protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3-K) pathways (Figure 1.1).  
Through insulin stimulation of the PI3-K pathway, GLUT4 translocates to the plasma membrane 
to stimulate skeletal muscle glucose uptake (Mul et al., 2015). Glucose is then delivered to and 
taken up by the muscle thorough GLUT-4 mediated facilitated diffusion transport through the 
plasma membrane (Richter and Hargreaves, 2013). When inside the muscle glucose is 
converted to glucose-6-phosphate (G6P) by hexokinase and then enters glycolysis to be utilized 
immediately, alternatively in a resting state it can be used for glycogen synthesis and storage 
(glycogenesis) (Richter and Hargreaves, 2013). The present glycogen stores within the skeletal 
muscle can be utilized through glycogenolysis which involves the breakdown of glycogen into 
G1P and G6P to then enter glycolysis (Jensen and Richter, 2012). Glycolysis involves the 
breakdown of G6P into pyruvate. Phosphofructokinase (PFK) regulates the conversion of 
fructose-6-phosphate into fructose-1, 6-disphosphate ultimately producing 2 molecules of 
pyruvate (Mul et al., 2015). Finally, the pyruvate is transported into the mitochondria via the 
mitochondrial carrier proteins MPC1 and MPC2. This is followed by oxidation of pyruvate by 
the pyruvate dehydrogenase complex (PDH) to 1 molecule of CO2 and 1 molecule of acetyl-
CoA. The final step is oxidation of acetyl-coA to 2 molecules of CO2 in the tricarboxylic acid 
(TCA-cycle) (Spriet, 2014).  
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1.2.3 IRS-PI3-K Signalling Pathway   
When circulating insulin binds to the insulin receptor located on the plasma membrane it 
activates a cascade of events. The insulin receptor substrate-1 (IRS-1) protein is stimulated 
consequently activating PI3-K (Lizcano and Alessi, 2002). Following the activation of PI3-K, 
phosphatidylinositol-bisphosphate (PIP2) is phosphorylated thereby producing 
phosphatidylinositol-3, 4, 5-triphosphate (PIP3) (Shepherd, Withers and Siddle, 1998). Protein 
kinase B (PKB/Akt) phosphorylation is one of the fundamental reactions following the creation 
of PIP3, and is used as a marker of the insulin signalling cascade action following activation by 
phosphoinositide-dependent kinase-1 (PDK1) (Kim et al., 2003). As a result, TBC1D4/AS160 
activity is increased, which converts the inactive form of Rab guanosine diphosphate (GDP) to 
its active form Rab guanosine triphosphate (GTP). Ultimately, TBC1D4/AS160 is a Rab GTPase-
activating protein that regulates the translocation of GLUT4 from microsomal storage 
microvesicles in the cytosol of the muscle fibres into the plasma membrane. This mechanism 
leads to increased uptake of blood glucose uptake into the muscle fibres (Lizcano and Alessi, 
2002) (Figure 1.1).  
Under basal conditions approximately 2 – 5% of GLUT4 is found at the plasma membrane 
(Kanzaki, 2006; Brewer et al., 2014). Transport of GLUT4 molecules from the microsomal 
storage vesicles to the plasma membrane occurs along microtubules formed by linear 
polymerisation of actin molecules (Lopez et al., 2009). Following insulin stimulation through 
meal ingestion, increases in GLUT4 transport to the plasma membrane at the cell surface occur 
thus allowing greater uptake of glucose in the muscle fibers (Lauritzen et al., 2006). Novel 
immunofluorescence microscopy methods have confirmed that there is a modest increase in 
GLUT4 at the plasma membrane in human skeletal muscle subsequent to glucose feeding 
(Bradley et al., 2015).  
1.2.4 Vascular responses to insulin 
The vascular responses induced by insulin are important in the augmentation of glucose 
disposal in skeletal muscle and other insulin-target tissues via vasodilation and increased blood 
flow (Bertrand et al., 2008). Insulin is essential to augment the production of nitric oxide (NO), 
a potent vasodilator produced by the vascular endothelium. The activation of endothelial NO 
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synthase (eNOS) is regulated by the insulin-signalling pathway and requires the activation of 
PI3K/PKB/Akt pathway. The activity of eNOS is enhanced through the PKB/Akt phosphorylation 
of eNOS thus increasing the production of NO (Bertrand et al., 2008). Meal-induced increases 
in plasma insulin concentration accelerate arterial blood supply to skeletal muscle leading to a 
50%-80% increase in skeletal muscle resting blood volume in healthy individuals (Vincent et al., 
2006). This increase in blood supply and volume induces an increase in the delivery of insulin, 
glucose, FAs, TAGs and amino acids to skeletal muscle (Wagenmakers et al., 2016). Skeletal 
muscle and subcutaneous adipose tissue are responsible for a large proportion of the clearance 
of orally ingested glucose and lipid (65-70%), and therefore make an important contribution to 
postprandial glucose and lipid homeostasis (Wagenmakers et al., 2016). Meal-induced 
increases in plasma insulin fail to increase blood volume in the skeletal muscle of obese 
individuals, sedentary elderly individuals and T2D patients (Clerk et al., 2006; Keske et al., 
2009), thus suggesting that blood flow to the skeletal muscle in the previously mentioned 
conditions is either reduced or absent in the postprandial period. This impairment following 
meal ingestion explains the hyperglycaemia seen in these individuals (Wagenmakers et al., 
2016). 
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Figure 1.1. The insulin signalling cascade featuring lipid induced insulin resistance and inflammation. FA, fatty acid; DAG, diacylglycerol; IMTG, intramuscular triglyceride; PKC, 
protein kinase C; nPKC, novel protein kinase C; aPKC, atypical protein kinase C; PP2A, phosphoprotein phosphatase 2A; TNF-, tumour necrosis factor alpha; IL-6, interleukin-
6; PIR, pro-inflammatory receptor; IR, insulin receptor; IRS-1, insulin receptor substrate-1; PI3-K, phosphoinositide 3-kinase; PKB/Akt, protein kinase B; AS160, Akt substrate of 
160 kD; Rab-GDP, Rab guanosine diphosphate; Rab-GTP, Rab guanosine triphosphate; GLUT4, glucose transporter-4; eNOS, endothelial nitric oxide synthase; NO, nitric oxide; 
Grb2, growth factor receptor-bound protein 2; SOS, son of sevenless; MAPK, ras-mitogen-activated protein kinase; ERK, extracellular-signal-regulated kinase; JNK, c-Jun N-
terminal kinase. 
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1.3 Intramuscular triglycerides and lipid droplets  
The majority of the lipid in our body is stored within adipose tissue (~9-15 kg) with a small 
quantity deposited in skeletal muscle (~350 g) (Frayn, Arner and Yki-Jarvinen, 2006). The lipid 
in skeletal muscle is stored in the form of intramuscular triglycerides (IMTG) that are packaged 
with a surrounding phospholipid membrane to form lipid droplets (LD). As highly dynamic 
organelles, LDs are involved in several diverse complex functions; cell signalling, mitochondrial 
fuel source and vesicle trafficking (Coen and Goodpaster, 2012). The primary role of LDs is to 
store TAG and it is suggested that dysregulation in LD homeostasis is implicated in the 
pathogenesis of insulin resistance and T2D (Greenberg et al., 2011). Additionally, the buffering 
capabilities of LDs regulates the cellular amounts of potentially toxic lipids thereby suggesting 
a prominent role in the prevention of lipotoxicity and oxidative stress (Olzmann and Carvalho, 
2019).  
1.3.1 LD structure and formation 
LDs have a unique architectural structure consisting of a hydrophobic core of neutral lipids 
(TAG and cholesterol esters), which is surrounded by a phospholipid monolayer that is 
decorated with a specific set of proteins (Ohsaki et al., 2009; Olzmann and Carvalho, 2019). It 
is suggested that LDs originate from, or in close proximity to, the endoplasmic reticulum (ER), 
although the exact mechanism by which this occurs is still equivocal particularly within skeletal 
muscle. Gradual accumulation of lipid esters; TAG and cholesterol between the leaflets of the 
ER bilayer increase the expansion of the neutral lipid lens which instigates LD budding from the 
ER membrane towards the cytoplasm (Bersuker and Olzmann, 2017). When using freeze-
fracture high resolution electron microscopy analysis in cultured human macrophages, it has 
been shown that ER membranes lie external to and follow the contour of LDs with similarity to 
an egg in an egg cup (Robenek et al., 2006). The membrane surface tension also appears to be 
important in the acquisition of the LDs rounded shape and its budding directionality (towards 
the cytosol). Phospholipids and proteins mask the oil-water interface consequently influencing 
the surface tension thereby suggesting alterations in protein and/or lipid composition between 
membrane monolayers is sufficient to induce tension imbalances (Olzmann and Carvalho, 
2019).  
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1.3.2 LD morphology and distribution 
Newly formed LDs are approximately <0.5 μm in diameter and referred to as ‘primordial’ LDs 
(Marchesan et al., 2003). However, LDs have the capacity to significantly increase/decrease in 
size though three key mechanisms; 1) via pores in the phospholipid monolayer the coalescence 
of fusion between two LDs occurs resulting in the fusion and exchange of lipids, 2) ripening of 
LDs through an exchange of molecules from one LD to another which results in increase LD size 
alongside a decrease in size of other LDs and 3) LD expansion through IMTG synthesis fuelled 
by an excess of FAs (Gemmink et al., 2017).  In the skeletal muscle of healthy individuals LD 
diameter (of ‘mature’ LD) is reported to range from 0.3 – 1.5 μm, however LD diameter is 
shown to increase up to 3.5 μm within obese individuals (Bosma, 2016). Furthermore, 
endurance trained athletes have shown greater LD density (number) compared to T2D patients 
(van Loon et al., 2004), with reports of a greater number of small-size LDs within type I fibres 
compared to type II fibres (van Loon et al., 2003; Shepherd et al., 2013b; Nielsen et al., 2017). 
It is accepted that a greater density of small-sized LDs is metabolically advantageous due to the 
higher surface area-to-volume ratio of small LDs resulting in lower lipid interference compared 
to larger LDs. The smaller LD provide a greater surface area for lipases to access and may 
increase phospholipid availability for regulatory proteins to associate with (Gemmink et al., 
2017).  
In addition to LD size and density, the subcellular location of LDs is also an important factor to 
consider in the development of insulin resistance. LDs are predominantly situated between the 
myofibrils (intermyofibrillar), however they have also been observed near to the plasma 
membrane within the subsarcolemmal region (Bosma, 2016). Increased LD density within the 
subsarcolemmal region has been associated with the development of insulin resistance, with 
obese and insulin resistant individuals having a greater number of large-size LDs within this 
region compared to lean individuals (Nielsen et al., 2010; Chee et al., 2016). In skeletal muscle 
of healthy individuals LDs are primarily located adjacent to mitochondria (Shaw, Jones and 
Wagenmakers, 2008). This distribution makes the LDs a readily available source of FA for the 
neighbouring mitochondria, particularly during exercise (Bonen, Dohm and van Loon, 2006). 
During moderate intensity exercise in healthy trained individuals, the oxidation of LDs makes 
an important contribution to the total adenosine triphosphate (ATP) production (energy 
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expenditure) (Krssak et al., 1999; Guo, Burguera and Jensen, 2000; van Loon et al., 2003; 
Shepherd et al., 2013b; Whytock et al., 2017).  
1.3.3 IMTG turnover  
IMTG is an important fuel source for skeletal muscle activity and its content depends on the 
balance between continuous synthesis and degradation of the IMTG pool (Sacchetti et al., 
2004). Healthy individuals have a greater capacity to utilise IMTG stores, implying that they are 
able to maintain a high turnover rate of the IMTG pool both during exercise (Guo, Burguera 
and Jensen, 2000) and at rest (Kanaley et al., 2009).  Furthermore, trained individual’s skeletal 
muscle has an enhanced oxidative and lipid storage capacity, with smaller sized LDs in direct 
contact with mitochondria which supports a higher IMTG turnover rate within athletes (Moro, 
Bajpeyi and Smith, 2008). This regular turnover of the IMTG pool is imperative in preserving 
optimal skeletal muscle insulin sensitivity (Sacchetti et al., 2004). 
1.4 Lipid metabolism  
Hormone sensitive lipase (HSL) and adipose triacylglycerol lipase (ATGL) are key enzymes in 
TAG lipolysis and are responsible for cleaving FA from the glycerol backbone from stored TAG 
in the adipose tissue and skeletal muscle (Shaw, Clark and Shepherd, 2013). The free fatty acids 
(FFA) from adipose tissue are then bound to albumin in the blood which then transports the 
FFA to skeletal muscle where they are taken up across the muscle membrane with the 
assistance of transport proteins primarily fatty acid translocase (FAT/CD36) (Bradley et al., 
2012). The FFA are activated by fatty acyl-CoA synthase upon entering the muscle and is either 
oxidised or used to synthesise IMTG. Stored IMTG can be utilized through lipolysis which 
releases FFA and is activated by HSL and ATGL (Spriet, 2011). For oxidation to occur all FFAs 
which were delivered from either the plasma or IMTG must be transported to the outer 
mitochondrial membrane. Short and medium chain fatty acids are able to enter the 
mitochondria directly; however the long chain fatty acid (LCFA) requires a transport system to 
cross the mitochondrial membrane which is regulated by carnitine palmitoyltransferase I (CPT-
I) (Spriet, 2011). The compound is then transported across the membrane via translocase, 
where carnitine moves in the opposite direction. Furthermore, the fat transport protein 
FAT/CD36, in conjunction with CPT-I, aids the transfer LCFA-carnitine to carnitine-acylcarnitine 
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translocase (CAT) and across the mitochondrial membranes for oxidation (Bezaire et al., 2006). 
When inside the mitochondria, carnitine is removed and the enzyme, carnitine 
palmitoyltransferase II (CPT II), rebounds CoA to the long chain fatty acid. (Spriet, 2011). Finally, 
through the -oxidation pathway the fatty acyl-CoA molecules are metabolised with the 
assistance of -oxidation enzymes, specifically -hydroxyacylCoA dehydrogenase (-HAD), in 
turn producing acetyl-CoA (Odland et al., 1998; Spriet, 2011). A substantial amount of energy 
is produced from lipid hydrolysis and subsequent oxidation of IMTG deposits in type I muscle 
fibres, predominantly during aerobic endurance-based activity (Bonen, Dohm and van Loon, 
2006) (Figure 1.2).  
1.4.1 Perilipin proteins regulating IMTG content   
Perilipins (PLIN) are proteins often associated with LDs, studded within the phospholipid 
monolayer of LDs. PLIN proteins facilitate storage during resting conditions and promote 
hydrolysis during exercise (lipolytic conditions) through interaction with lipid hydrolysing 
enzymes (Tansey et al., 2001). PLIN1-5 are proteins that play an extensive role in regulating 
lipolysis and TAG hydrolysis in adipose tissue, with PLIN2-5 also being expressed in skeletal 
muscle (Morales, Bucarey and Espinosa, 2017a). These PLIN proteins can be either exclusively 
associated with lipid droplets (PLIN1-2) or exchangeable proteins that are stable in either the 
cytoplasm or when associated with lipid droplets (PLIN3-5) (Sztalryd and Brasaemle, 2017). 
Similar to IMTG content, PLIN proteins have greater expression within the oxidative type I 
skeletal muscle fibres in comparison to the type II fibres thereby mirroring the fibre-type 
specific distribution of IMTG (Shaw et al., 2012; Shepherd et al., 2013a; Pourteymour et al., 
2015). Furthermore, following exercise training PLIN2, PLIN3 and PLIN5 proteins levels are 
elevated within skeletal muscle together with increased IMTG content (Shaw et al., 2012; 
Shepherd et al., 2013a). It could be that increased PLIN protein content is relative to 
augmented IMTG content, therefore implying a potential mechanistic role of increased PLIN 
protein content which facilitates an increased IMTG pool within trained individuals. This 
potential mechanistic link between elevated PLIN protein and IMTG content has also been 
observed when examining sex differences.  Peters et al. (2012) reported that female skeletal 
muscle contains an abundance of PLIN2 and PLIN5 when compared to males, alongside higher 
IMTG content in the female skeletal muscle. The high expression of PLIN2, PLIN3 and PLIN5 in 
skeletal muscle positively correlates with LD content where it can interact with HSL, a 
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predominant enzyme involved in LD hydrolysis (Macpherson et al., 2013; Morales, Bucarey and 
Espinosa, 2017a). PLIN-coated LDs have been shown to be preferentially oxidised during 
moderate-intensity exercise, potentially by HSL being preferentially recruited to LDs (Shepherd 
et al., 2012; Shepherd et al., 2013b; Whytock et al., 2018). Interestingly, (Jevons et al., 2020) 
reported that PLIN proteins do not appear to be involved in mediating IMTG resynthesis due 
to an inconsistency within the time course observed between the increased IMTG pool and the 
coating of LDs with PLIN proteins. 
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Figure 1.2. IMTG metabolism in skeletal muscle. AGPAT, 1-acylglycerol-3-phosphate acyltransferase; 
ATGL adipose triglyceride lipase, ACS, acyl-CoA synthetase; DAG, diacylglycerol; DGAT, diacylglycerol 
transferase; FA, fatty acid; FA-CoA, fatty acyl-CoA; CD36, cluster of differentiation 36; G-3-P, glycerol-
3- phosphate; GPAT, glycerol-3-phosphate acyltransferase; HSL, hormone sensitive lipase; IMTG, 
intramuscular triglyceride; LPA, lysophosphatidic acid; MAG monoacylglycerol; MGAT, 
monoacylglycerol transferase; PA, phosphatidic acid. 
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1.5 Insulin Resistance  
During a healthy individual’s life cycle insulin sensitivity will naturally fluctuate. It has been 
proposed that these fluctuations predominantly occur during male and female puberty, 
pregnancy and with age. Consequently, an increase in insulin resistance has been observed 
following these fluctuations (Kahn, Hull and Utzschneider, 2006). Additionally, lifestyle is 
arguably one of the most important factors determining insulin sensitivity. For example, 
physical inactivity and excess energy intake lead to impaired insulin sensitivity, thus increasing 
the risk of developing T2D (Kahn, Hull and Utzschneider, 2006). Consequently, these individuals 
spend an increased time in the postprandial phase therefore exposing tissues to excessive FA 
and glucose concentrations. Reduced PA and structured exercise, increased sedentary 
behaviour and energy-dense westernised diets lead to the maladaptation of insulin sensitive 
tissues, whereby blood flow is reduced alongside the delivery of insulin thereby tissues become 
less responsive to the effects of insulin (Kasuga, 2006). Hyperglycaemia is the result of 
decreased glucose uptake into peripheral tissues (and predominantly skeletal muscle), a result 
of impaired insulin sensitivity within skeletal muscle. Furthermore hepatic insulin resistance 
can also result in hyperglycaemia through an impaired suppression of glucose production by 
insulin in hepatocytes. In obesity, the production of harmful proteins and metabolites is 
increased, namely retinol-binding protein-4 (RBP4), which induces insulin resistance through 
the stimulation of macrophages and CD4 cells to release inflammation cytokines which supress 
insulin signalling at the level of IRS. Additionally, β-cell function is significantly decreased (50%) 
in T2D patients reducing the insulin production in response to the ingestion of CHO-rich meals. 
The primary role of β-cell is to respond quickly to spikes in blood glucose concentrations 
through the production and release insulin and amylin which reduce blood glucose 
concentrations, and thus insulin secretion is increased to compensate for the elevated blood 
glucose concentration (Kasuga, 2006).  
1.5.1 Skeletal muscle insulin resistance  
Insulin resistance of skeletal muscle fibres is characterised by a downregulation of the intricate 
mechanisms involved in glucose uptake. These impairments result in a reduced capacity for 
translocation of GLUT4 from the microsomal storage vesicles to the plasma membrane, 
resulting in elevated blood glucose concentrations (Saltiel and Kahn, 2001). Furthermore, a 
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decrease in mitochondrial FA oxidation and/or reduced mitochondrial content results in an 
accumulation of intracellular long chain fatty Acyl-CoA’s, diacylglycerol (DAG) and ceramides, 
causing impaired insulin receptor signalling (Lowell and Shulman, 2005) (Figure 1.2). Skeletal 
muscle insulin resistance may also occur via impaired mitochondrial oxidative and 
phosphorylation activity, particularly within older and obese populations where mitochondrial 
function is reduced due to an increase in reactive oxygen species (ROS) activity (Petersen et 
al., 2003; Rindler et al., 2013; Samuel and Shulman, 2016). 
1.5.2 Lipid overflow hypothesis  
When postprandial clearance of chylomicron-TAG into adipose tissue becomes impaired there 
is an overspill of FA and TAG in the circulation (Frayn, 2002a). As a result of the impaired lipid 
buffering mechanisms and limited adipose tissue expansion, the excess lipids are deposited in 
non-adipose tissues and it is these ectopic lipid accumulations which prove detrimental to 
insulin sensitivity (Chadt et al., 2018). This accumulation of TAG in skeletal muscle of sedentary 
and obese individuals has previously been associated with insulin resistance (Goodpaster et 
al., 1997) as it acts as a potential surrogate for other harmful lipid metabolites which have a 
deleterious effect on lipid metabolism thereby impairing function (Chadt et al., 2018). 
1.5.3 Athletes paradox  
Earlier research demonstrates an association between IMTG content and insulin resistance. 
Through a reduction in FA oxidation there is an increase in lipid metabolite accumulation which 
characteristically impairs the insulin signing cascade thus increasing the risk of developing 
insulin resistance. The majority of studies that express this correlation were predominantly 
rodent based (Gajda et al.; Lee et al., 2006; Buettner, Schölmerich and Bollheimer, 2007; Wang 
and Liao, 2012). However, more recently, attempts have been made to investigate the complex 
relationship between LDs and insulin sensitivity within human participants (Daemen et al., 
2018; Daemen, van Polanen and Hesselink, 2018). Moreover, the data produced from all the 
above research papers collectively suggest that obese and T2D partcicipants have an 
accumulation of intramuscular lipid whilst also being highly insulin resistant (Schenk and 
Horowitz, 2007). 
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The athletes’ paradox describes the phenomenon whereby highly trained endurance athletes 
store large quantities of IMTGs in skeletal muscle, though they remain highly insulin sensitive 
(Goodpaster et al., 2001). Conversely, obese and T2D individuals accumulate IMTG whilst being 
highly insulin resistant (Schenk and Horowitz, 2007). This finding provides an insight to the 
relationship between IMTG and insulin resistance, suggesting that IMTG alone may not be 
accountable for reduced insulin sensitivity but possibly serve as a surrogate of other potentially 
disadvantageous lipid metabolites, including long-chain fatty-acyl CoAs, ceramides and DAGs 
(Goodpaster et al., 2001). 
1.5.4 Lipid metabolites  
TAG, DAG and cholesterol are the key esterified lipids which account for the majority of the 
lipid content in intramuscular LDs (Billecke et al., 2015). Recent evidence suggests that the 
reduced insulin action in obese and T2D populations is not caused by accumulation of IMTG, 
but by accumulation of DAGs and ceramides specifically in the peripheral region of the muscle 
fibres (Jocken et al., 2010). The general consensus is that DAGs and ceramide are the lipid 
metabolites responsible for the documented affiliation between intramuscular lipid 
accumulation and insulin resistance (Amati et al., 2011b). The increased abundance of DAGs 
has been proposed to stimulate novel protein kinase C (nPKC) isoforms, which are serine 
kinases. Serine phosphorylation of IRS-1 in skeletal muscle prevents tyrosine phosphorylation 
and therefore reduces insulin action (Kim et al., 2003). In addition, ceramides have been shown 
to dephosphorylate PKB/Akt, thereby further downregulating Akt activity and reducing the 
translocation of GLUT4 and limiting muscle glucose uptake (Itani et al., 2002) (Figure 1.1).  
The observation has been made that healthy sedentary obese controls and individuals with 
T2D have a higher total muscle DAG concentration than lean endurance-trained athletes 
(Bergman et al., 2012). The majority of DAG was present in the membrane fraction in the 3 
groups, but it was lowest in the athletes. No difference was seen for the cytosolic DAG species. 
Membrane DAG species were more abundant in the T2D group. Only total saturated DAG in 
the muscle membranes correlated with insulin sensitivity. Desaturated DAG species were 
significantly lower in the athletes, and significantly related to insulin sensitivity. The authors 
concluded that these data indicated that both cellular localisation and composition of DAG 
influence the relationship to insulin sensitivity and that the results suggested that only 
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saturated DAG in skeletal muscle membranes are related to insulin resistance in humans 
(Bergman et al., 2012). 
Ceramides are a family of lipid molecules composed of a sphingosine base and fatty acid 
moiety. It is apparent that an accumulation of ceramides inhibits insulin action and ceramides 
are suggested to be more closely related to insulin resistance than DAGs due to the consistent 
elevations in ceramides observed in obese and insulin resistant skeletal muscle (Amati et al., 
2011b). There are two proposed mechanisms, both centred on the inhibition of Akt/PKB 
stimulated by ceramides, which contribute to the disruption of the insulin signalling pathway. 
Firstly, the phosphorylation of Akt/PBK reduces its affinity for phosphoinositides as a result of 
increased atypical PKCζ activity which is stimulated by ceramides (Powell et al., 2003). 
Secondly, ceramides activate protein phosphatase 2A (PP2A) which dephosphorylates Akt/PKB 
thereby obstructing Akt/PKB recruitment to the plasma membrane by phosphoinositides 
(Chavez et al., 2003). Ultimately, these mechanisms reduce Akt/PKB recruitment to the plasma 
membrane by phosphoinositides which inhibits insulin-stimulated glucose uptake by hindering 
the activation of AS160 and GLUT4 translocation to the plasma membrane (Chavez and 
Summers, 2012). 
The insulin signalling cascade has been shown to be disrupted by the accumulation of lipid 
metabolites. The deleterious accumulation of LDs in skeletal muscle can occur due to an 
inability to match lipid oxidation to lipid availability and/or an impaired TAG turnover, the 
equilibrium of TAG storage and removal into adipocytes (Moro, Bajpeyi and Smith, 2008). This 
is seen in sedentary and obese individuals who fail to empty their IMTG stores to fuel exercise, 
combined with a high FA flux into the skeletal muscle of obese individuals may result in the 
accumulation of lipid metabolites. Additionally, the number of LDs close to the plasma 
membrane is inversely related to insulin sensitivity, and it is thought that insulin resistant 
individuals express a greater number of large LDs within the subsarcolemmal region of the 
muscle fibre which, in absence of an increased mitochondrial density, hinders cells signalling 
and ultimately leading to an increased risk of insulin resistance (Daemen et al., 2018).  
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1.5.5 Inflammation 
The link between inflammation and insulin resistance was first put forward by  Hotamisligil, 
Shargill and Spiegelman (1993), who demonstrated that an increased expression of 
proinflammatory cytokines, more specifically tumour necrosis factor alpha (TNF-), is 
positively linked with the development of insulin resistance (Figure 1.1). Further, in human 
adipose tissue TNF- expression declined following weight loss, suggesting that its expression 
plays an important role in adipocyte metabolism and could be a homeostatic mechanism in the 
development of insulin resistance (Kern et al. 1995). There is also increasing evidence that the 
production of the cytokine interleukin 6 (IL-6) is involved in the stimulus of C-reactive protein 
(CRP) synthesis (Ferroni et al., 2004). CRP levels have previously been correlated with insulin 
resistance (Festa et al., 2000), suggesting that increased IL-6 expression may contribute to the 
development of insulin resistance (Figure 1.1). Interestingly, the expression of TNF- promoter 
(G-308A) is associated with the risk of developing type 2 diabetes, whereas the IL-6 promoter 
(C-124G) increases an individual’s risk for insulin resistance (Dandona, Aljada and 
Bandyopadhyay, 2004). Additionally, the activation of compliment  factor 3 initiates 
inflammatory responses which proceed with further lymphokine (a subset of cytokines) 
production and secretion, ultimately leading to an increase in adipocyte lipolysis, nonesterified 
fatty acid (NEFA) production and insulin resistance in skeletal muscle (Grundy et al., 2004). 
1.6 Mitochondria  
Frequently termed the ‘powerhouse’ of the cell, mitochondria are crucial organelles in the 
synthesis of ATP. However, mitochondria also play an extensive role in other cellular processes, 
including FA synthesis (Bezaire et al., 2006).  A common theory within research, suggests that 
mitochondria are significant factors in the development of insulin resistance (Kim, Wei and 
Sowers, 2008). However, there are conflicting views regarding the exact mechanisms by which 
mitochondria contribute to the pathogenesis of insulin resistance (Di Meo, Iossa and Venditti, 
2017). One of the widely accepted theories proposes that a decrease in mitochondrial 
oxidation of FAs is caused by a dysfunction and decrease in mitochondrial content thus leading 
to an accumulation of intracellular fatty acyl-CoA, DAG and ceramides which inhibit insulin 
signalling (Lowell and Shulman, 2005; Coen and Goodpaster, 2012).  
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1.6.1 Improved mitochondrial function and content following physical activity  
It is well established that a high physical activity level has a positive impact on mitochondrial 
density and function and insulin sensitivity in skeletal muscle (Lanza and Nair, 2008; Meex et 
al., 2010; Montgomery and Turner, 2015; Olver, Laughlin and Padilla, 2019). Aerobic exercise 
activates signals that induce greater oxidative capacity, thus leading to mitochondrial 
biogenesis and angiogenesis which generates a dense 3-dimensional capillary network around 
the skeletal muscle fibres. In addition to improved mitochondrial function, aerobic exercise 
improves insulin action, leading to an augmented translocation and protein content of GLUT4 
(Richter and Hargreaves, 2013) irrespective of gender or age (Ojuka, Goyaram and Smith, 2012; 
Bird and Hawley, 2016; Brook et al., 2016). Exercise training induces greater oxidative capacity 
due to increased beta-oxidation via the mitochondria, subsequently lipid oxidation is increased 
as is the capacity for lipolysis, therefore skeletal muscles ability to extract FAs from plasma 
following meal-ingestion is improved (Flück, 2006). Furthermore, DAG, ceramide and long-
chain fatty acyl-CoA concentrations are maintained at concentrations which do not activate 
PKCs and lead to insulin resistance of the muscle fibres and their microvasculature (Amati et 
al., 2011b).  Glycogen synthase is also activated following exercise due to consistent reduction 
of muscle glycogen stores thus increasing rate of glucose uptake from the blood following 
carbohydrate meal-ingestion. Glycogen and IMTG depletion during frequent bouts of exercise 
create storage space for meal derived carbohydrates and lipids. Therefore, a physically active 
lifestyle may prevent unfavourable changes within blood glucose and lipid concentrations 
following meal-ingestion, which is commonly seen in sedentary, insulin resistant and T2D 
patients (Wagenmakers et al., 2006).  
Oxidative capacity also plays an important role in insulin sensitivity. LDs are predominantly 
adjacent to the mitochondria with greater abundance and size in the oxidative type I fibres 
than type II fibres (He, Goodpaster and Kelley, 2004; Shaw, Jones and Wagenmakers, 2008; 
Coen et al., 2010). Furthermore, in trained individuals, LDs act as a readily available fuel source 
during exercise as they are located near the mitochondria within the subsarcolemmal region 
of the myofibre (Hoppeler, 1999; van Loon et al., 2003). In comparison, obese individuals 
present reduced oxidative capacity due to reduced mitochondrial content (Kim et al., 2000) 
and therefore a reduced capacity to utilise IMTG as a fuel source. In addition to this, the 
number of LDs close to the plasma membrane is inversely related to insulin sensitivity, and it 
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has been proven that endurance training only increases the number of LDs but does not alter 
the size (Tarnopolsky et al., 2007). Exercise may be used as a non-pharmacological treatment 
to improve diseased individual’s oxidative capacity. Following four months of exercise training, 
obese individuals showed alterations in LD size due to concomitant increase in oxidative 
capacity the LD size is reduced which can correlate to an improved insulin sensitivity (He, 
Goodpaster and Kelley, 2004). 
1.6.2 Mitochondrial dysfunction and insulin resistance  
The relationship surrounding mitochondria and insulin sensitivity has been an area of interest 
and debate within research for decades. There are various views and hypotheses regarding 
mitochondrial dysfunction and its role in insulin resistance presented within literature. These 
among others include a reduction in content and/or quality of the mitochondria. A popular 
view amongst studies suggests that insulin action in skeletal muscle is driven by enhanced 
oxidative capacity which is improved through increased physical activity leading to greater 
mitochondrial content (Rimbert et al., 2004; Phielix et al., 2010). However, Muoio and Neufer 
(2012) proposed that mitochondrial load, ROS signalling and redox pressures (induced by 
increased energy supply which continuously surpasses energy demand) are determinants of 
skeletal muscle insulin resistance more so than oxidative capacity alone. Moreover, human 
based studies which included obese and T2D patients found reduced mitochondrial size, 
biogenesis and a downregulation in oxidative phosphorylation pathways when compared to 
lean healthy individuals (Montgomery and Turner, 2015).  From these studies it was suggested 
that improved mitochondrial function (density and oxidative enzyme activity) resulted in 
improved insulin sensitivity when exercise and caloric restriction was administered 
(Montgomery and Turner, 2015). Finally, it has also been proposed that mitochondria also play 
an extensive role in age-related diseases, primarily metabolic diseases which encompass 
insulin resistance and the progression of T2D. This is driven through reduced circulating small 
human-like peptides 2 (SHLP2) levels within older populations. SHLP2 is derived from the 
mitochondrial genome and is associated with increased leptin levels which in turn can improve 
insulin sensitivity (Cobb et al., 2016). The conflict within research suggest that there is a highly 
complex relationship between mitochondria and insulin action which requires further 
investigation to fully understand these intricate mechanisms.  
33 
 
1.7 Sex differences in metabolism and insulin sensitivity 
It has become increasingly apparent from research that glucose and lipid metabolism may be 
subject to sex-specific regulation, with evidence of molecular sex differences in substrate 
metabolism of skeletal muscle (Lundsgaard and Kiens, 2014).  The higher insulin sensitivity of 
female skeletal muscle could be an outcome of multiple sex differences previously observed in 
research; greater type I fibre distribution and substrate availability, improved skeletal muscle 
oxidative capacities and the expression of key sex hormones in females (17- estradiol) 
(Lundsgaard and Kiens, 2014). Interestingly, female skeletal muscle contains greater lipid 
stores when compared to males whilst also demonstrating greater abilities of insulin-
stimulated glucose clearance in skeletal muscle. Previous findings imply that females have 
greater metabolic flexibility due to their ability to adjust substrate oxidation in accordance to 
the availability of nutrients during physical activity and exercise (Lundsgaard and Kiens, 2014). 
However, research investigating these sex differences in substrate metabolism is limited and 
requires further investigation to fully understand the role of sex in metabolism and the specific 
sex differences in molecular mechanisms which could lead to enhance understanding of 
metabolic dysfunctions. 
1.7.1 Adipose tissue storage  
There is a greater prevalence of T2D in males compared to females (Wild et al., 2004). Pre-
menopausal females display greater insulin sensitivity compared to their BMI matched male 
counterparts despite their significantly greater adipose tissue mass (Geer and Shen, 2009). 
Furthermore, pre-menopausal females also display lower risk of metabolic and cardiovascular 
complications compared to males (Clausen et al., 1996). Moreover, it has been proposed that 
the female’s ability to store a greater adipose tissue mass whilst remaining insulin sensitive is 
due to the regions in which the adipose tissue is stored. Females predominantly deposit fat in 
the lower regions of the body, as opposed to the upper regions (more specifically the 
abdominal area) as noted in males which increases the risk of metabolic complications (Janjic, 
1996). 
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1.7.2 Sex hormones  
Previous literature suggests that sex hormones contribute largely to the differences recorded 
between sexes and insulin sensitivity (Geer and Shen, 2009; Basu, Dube and Basu, 2017). Pre-
menopausal females have a reduced risk of T2D and cardiovascular diseases compared to 
males and post-menopausal females (Pérez-López et al., 2010), although the literature 
surrounding the mechanisms underpinning this phenomenon is limited.  Currently, it is 
suggested that the female sex hormones (oestrogen and progesterone) serve to protect 
against metabolic risk factors (Geer and Shen, 2009). However, during menopause, production 
of the female sex hormone, oestrogen, ceases thus increasing the risk of cardiovascular disease 
and T2D (Polotsky and Polotsky, 2010). Research has investigated the menopause-related 
declines in insulin sensitivity and oestrogen secretion through hormone replacement therapy 
using oestrogen infusion. This treatment results in an increased rate of glucose disposal with 
the potential to counter metabolic risk through an increase in insulin sensitivity (Spencer et al., 
2000; Van Pelt et al., 2003). Female sex hormones, and particularly oestrogen, therefore 
appear to contribute to the higher insulin sensitivity of pre-menopausal women. However, the 
current research surrounding these intricate mechanisms is limited, and even more so in post-
menopausal women whom appear to lose the protective benefits of sex hormones thus 
increasing susceptibility to metabolic health defects. Males also experience a decline in 
testosterone levels during older age which is suggested to negatively impact lipid metabolism 
and insulin signalling. Evidently, testosterone improves insulin action and glucose metabolism 
through various mechanisms; increased GLUT4 expression, reduced pro-inflammatory 
cytokines, decreased LPL activity and mitochondrial function (Ottarsdottir et al., 2018). 
Testosterone may protect against the development of insulin resistance in males through 
preservation of muscle mass and function, however age related reductions in testosterone 
levels may be involved in the etiology of sarcopenia with evidence of decreased muscle mass 
and/or function related to low testosterone levels (Shin, Jeon and Kim, 2018).  
1.7.3 Skeletal muscle IMTG content and utilisation  
It is evident that females have a greater utilisation of IMTG during exercise, however it has 
been speculated that this is a result of higher IMTG concentrations within female skeletal 
muscle prior to exercise (van Loon, 2004). Furthermore, the greater IMTG content within 
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females may be attributed to higher plasma FFA availability and FAT/CD36 protein expression 
in muscle (Lundsgaard and Kiens, 2014). Females also have a greater number of smaller LDs 
compared to males, which would theoretically increase the accessibility of lipases and proteins 
associated with LDs to the stored IMTG (Devries et al., 2007). Collectively, the smaller LDs and 
increased perilipin protein expression observed within female skeletal muscle is likely to 
increase the physical link between LDs and mitochondria, thereby augmenting IMTG turnover 
(Lundsgaard and Kiens, 2014). Furthermore, the smaller LDs in women have been documented 
near mitochondria following a bout of exercise proposing that women have enhanced IMTG 
oxidation capabilities (Devries et al., 2007). Interestingly, previous research suggest that 
mitochondrial content is similar within men and women (Tarnopolsky et al., 2007), yet females 
present greater mitochondrial function in comparison to males (Tower, 2006). It is 
hypothesised that the improved mitochondrial function observed within females is attributed 
to the positive action of oestrogen (Ventura-Clapier et al., 2017). However, following 
menopause the protective mechanisms of oestrogen are not available, therefore leading to 
mitochondrial dysfunction which is often associated with cardiovascular disease and metabolic 
syndrome (Ventura-Clapier et al., 2017). Nevertheless, the limited research investigating IMTG 
and mitochondrial content has shown greater IMTG content (due to greater IMTG size) 
alongside a decline in mitochondrial (due to reduced number) in older adults with female 
skeletal muscle containing a greater amount of IMTG compared to males (Crane et al., 2010). 
The studies previously discussed predominantly include pre-menopausal females, however the 
apparent gap within the current literature is the effects of menopause on female lipid 
metabolism and the result of diminished hormone protection in older females.  
1.7.4 Fibre types and oxidative capacity  
Women exhibit greater whole-body fat oxidation in comparison to males during submaximal 
exercise, thereby implying that females have a greater reliance on fat oxidation in comparison 
to males (Devries et al., 2007; Cheneviere et al., 2011). Furthermore, females show greater 
IMTG oxidation, adipose tissue lipolysis and a higher contribution of plasma FFAs to total fat 
oxidation during endurance exercise (Mittendorfer, Horowitz and Klein, 2002; Roepstorff et 
al., 2002). These findings are almost exclusively observed within pre-menopausal women who 
were not taking oral contraceptives and were controlled for phases of the menstrual cycle 
(Cheneviere et al., 2011). However, it is proposed that the menstrual cycle and oral 
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contraceptives possibly influence fat metabolism, with reported greater lipid utilization in the 
luteal phase when compared to the follicular phase (Devries et al., 2006). Females also have a 
greater area percentage of type I muscle fibres compared to type II muscle fibres and a greater 
capillary density per given muscle area in comparison to males (Roepstorff et al., 2006). Type I 
muscle fibres have a greater oxidative capacity due to a more expansive and complex 
mitochondrial network and associated oxidative enzymes, thus allowing for a more efficient 
fatty acid and glucose metabolism (Shaw, Jones and Wagenmakers, 2008). This in turn may 
help to prevent the accumulation of lipotoxic metabolites in the muscle as FA oxidation can 
match the FA delivery. Lipid metabolites can be removed from the cytosol by being oxidised or 
through re-synthesis into TAG and stored as lipid droplets in the skeletal muscle cell (Walther 
and Farese Jr, 2012). Furthermore, research has found an increased mRNA content of genes 
involved in lipid metabolism in female skeletal muscle in comparison to males partially due to 
17- estradiol (Peroxisome proliferator-activated receptor; PPAR, PPARδ), suggesting that 
females are able to store a greater number of LDs in comparison to males and remain insulin 
sensitive through oxidising IMTG and using stores as a fuel source during exercise (Fu et al., 
2009).  
1.8 Immunofluorescence Microscopy 
Earlier research investigating lipid metabolism has predominately been on whole muscle 
samples (Bergman et al., 2010). This is a considerable oversight as more recent research 
suggests that lipid metabolism appears to be dependent upon fibre-type and subcellular 
location (Gemmink et al., 2017; Whytock et al., 2020). It is imperative that research utilises 
progressive lipid metabolism research techniques when possible to address these deficiencies. 
As a research technique, immunofluorescence microscopy has proven invaluable when 
producing novel data as well as presenting informative images which clearly exhibit the 
distribution and morphology of specific proteins. It was immunofluorescent microscopy that 
successfully identified a matrix structure in which LDs and mitochondria are present, and that 
the LDs are primarily located in close proximity to the mitochondria (Shaw, Jones and 
Wagenmakers, 2008). Using published immunohistochemically methods ensures credibility 
and reliability of this thesis due to the accuracy that the methods provide when examining LDs 
(Strauss et al., 2016; Whytock et al., 2017). These methods exclude analysis of extra 
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myocellular lipids which warrants the validity of the research through examining the samples 
LDs with regards to specific fibre types.  
Within previous literature, there is a lack of information surrounding the different fibre types 
in skeletal muscle. Studies that use traditional research methods such as Western Blots or Mass 
Spectrometry provide limited information regarding fibre type specific differences in lipid 
profile, typically whole skeletal muscle tissue is analysed to produce a total estimate of IMTG 
content (Bass et al., 2017; Ko et al., 2018). Therefore, future research focusing on fibre type 
differences is imperative to develop a better understanding of the difference in metabolic 
characteristics of the fibres and how this may impact lipid content and turnover, oxidative 
capacity and IMTG use during exercise (Jevons et al., 2020).  
The main advantage of using immunofluorescence microscopy is the additional information it 
provides concerning fibre type specific differences in the distribution, morphology and 
utilization of lipid (van Loon et al., 2004; Shaw, Jones and Wagenmakers, 2008). Furthermore, 
this analytical technique can potentially develop current perceptions surrounding the 
impairments in lipid metabolism of skeletal muscle and its potential deleterious effect on 
glucose uptake and insulin sensitivity. Therefore, it is essential that new 
immunohistochemically methods are developed to address future research questions that may 
provide further insight to the understanding of intricate mechanisms involved in the 
impairment of lipid metabolism presented in obese individuals leading to insulin resistance in 
skeletal muscle. 
1.9 Limitations  
Previous research investigating the link between lipid metabolism and insulin resistance has 
almost exclusively been conducted in male participants. Pre-menopausal females display 
greater insulin sensitivity when compared to BMI-matched males despite having larger body 
fat stores, which would normally be associated with insulin resistance (Geer and Shen, 2009). 
It is essential that research now provides novel data on the determinants of sex differences in 
the characteristics and distribution of LDs in skeletal muscle. Such data could begin to elucidate 
the protective physiological mechanisms that enable females to maintain higher insulin 
sensitivity despite having larger body fat stores than their BMI-matched male counterparts. 
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Previous research also demonstrates a significant limitation with regards to health status and 
sex, with the majority of research predominately conducted in obese, T2D and trained males.  
1.10 Aims  
It is thought that fibre type distribution, subcellular location, size and number of LDs relate to 
insulin sensitivity more so than IMTG content per se (Coen and Goodpaster, 2012), however 
this theory requires further investigation in human skeletal muscle (Bergman et al., 2012). Sex 
hormones are also likely to play a role in the higher insulin sensitivity previously observed in 
pre-menopausal women compared to male counterparts, however, the difference between 
men and post-menopausal women is not apparent. With an increasing focus on personalised 
diet and nutrition interventions/advice, research on metabolic processes in females is much 
needed. The study focused on addressing these significant gaps within the literature in relation 
to female metabolism, which has almost exclusively been conducted within pre-menopausal 
females. The aim of the present study was to 1) establish a better understanding of the sex 
differences in the relationship between LD profile, mitochondrial density and the development 
of insulin resistance thereby 2) contributing to current and future research improving insulin 
sensitivity and preventing the progression of insulin resistance. These aims would be achieved 
through 1) identifying fibre and region specific differences in the subcellular distribution and 
morphology of lipid droplets in human skeletal muscle of lean sedentary, obese and T2D males 
and females, 2) Identify the participants skeletal muscle fibre-type specific differences in 
mitochondrial density, and finally 3) Establish a better understanding of the relationship 
between mitochondrial density, lipid droplet distribution/morphology and insulin sensitivity.  
It is hypothesised that females have greater LD stores compared to males whilst remaining 
insulin sensitive, and that type two diabetes (T2D) patients have greater LD stores compared 
to the lean and obese participants.  
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2. Materials and Methods 
2.1 Participants and ethical approval  
The design of the study was a cross-sectional comparison. A cohort of older males (n=24) and 
females (n=24) were matched for physical activity (international physical activity questionnaire 
(IPAQ)), BMI (kg.m-2) and age (see Table 2.1 for participants characteristics). Participants were 
allocated into one of three groups based on their BMI; Lean, Obese and Obese T2D. Each group 
included eight males and eight females (n = 16). All participants were undergoing surgery (see 
2.2) at either the Royal Orthopaedic Hospital, Birmingham, UK or Russell’s Hall Hospital, 
Dudley, UK and gave their informed written consent for participation in this study. Participant’s 
use of medication was also obtained (Table 2.2). Ethical approval for the study in this thesis 
was obtained from the Black Country NHS Research Ethics Committee [09/H1207/137] with 
adherence to the Declaration of Helsinki. 
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Table 2.1 Participants Characteristics  
 Female Male 
 Lean Obese T2D Lean Obese T2D  
N 8 8 8 8 8 8  
Age (y) 64 ± 3 65 ± 5 64 ± 2 67 ± 2 60 ± 4  61 ± 3  
Body Mass (kg) 60.0 ± 3.6 84.0 ± 3.6 88.4 ± 3.6 76.7 ± 3.0 97.0 ± 4.1 109.7 ± 5.4  
Height (m) 1.60 ± 0.03 1.62 ± 0.03 1.65 ± 0.02 1.73 ± 0.01 1.76 ± 0.02 1.76 ± 0.02  
BMI (kg.m-2) 22.7 ± 1.1 32.2 ± 1.4 32.6 ± 1.2 25.6 ± 0.6 31.4 ± 0.8 35.4 ± 1.7  
Systolic BP (mmHg) 129 ± 6 132 ± 8 139 ± 9 135 ± 4 132 ± 4 145 ±  3  
Diastolic BP (mmHg) 80 ± 2 79 ± 5 67 ± 3 77 ± 3 80 ± 4 89 ± 4  
Plasma glucose (mmol/L) 6.99 ± 0.31  6.08 ± 0.31  10.04 ± 1.05*  5.22 ± 0.41   6.44 ± 0.36  8.71 ± 0.80*   
Plasma insulin (pmol/L) 107.64 ± 31.51 141.67 ± 67.13 208.58 ± 50.17* 98.89 ± 15.27 155.96 ± 110.04 157.22 ± 63.68  
HOMA-IR 4.80 ± 0.66† 5.77 ± 1.33 13.39 ± 2.20*† 3.27 ± 0.33 6.94 ± 2.10 8.68 ± 1.44*  
Data provided as means ± SD. BMI; body mass index, HOMA-IR; homeostatic model assessment of insulin resistance. *Health x sex interaction (P < 0.05). †Sex 
x health interaction (P < 0.05)
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Table 2.2 Participants medication  
Medication  Lean Obese T2D 
Adcal D3 1 1 0 
Alendronic acid 1 0 0 
Amiodarone 1 0 0 
Amlodipine 0 0 2 
Amytryphline 0 0 1 
Aspirin  3 1 6 
Atenotol 0 0 1 
Athrotec 0 0 1 
Atorvastatin  0 1 2 
Becotide 0 1 0 
Bendopamethazide  1 0 0 
Bisoprolol  2 0 0 
Butrans patch  0 0 2 
Calceos  1 0 0 
Cardiolplen 0 1 0 
Casipt 0 1 0 
Citalopram 0 0 2 
Co-amilofruse 0 0 1 
Co-codamol  2 0 2 
Codeine 0 0 0 
Co-drydamol 0 1 1 
Corclazide 0 0 1 
Dasulepin 0 1 0 
Dermovate cream 0 0 1 
Diazepam  0 0 1 
Diclofenac 1 0 1 
Dihydrocodiene 1 1 2 
Dosulapin 0 1 0 
Doxasosin 0 0 1 
Enoxaporin 0 1 0 
Felodipine 1 0 0 
Ferous fumerate 1 0 0 
Flucticasone inhaler  1 0 0 
Frusemide  0 0 1 
Furosemide 0 0 1 
Gaviscon 0 0 1 
Glucazide 0 0 1 
Glucaziele 0 0 1 
Glucodaside 0 0 1 
Glucosamine 1 0 0 
GNT 0 1 1 
HTN  0 0 1 
Hypremellose 1 0 1 
Ibandronic acid  1 0 0 
Ibuprofen  1 0 1 
Ibuprofen gel  1 0 0 
Imipramine 1 0 0 
Indomatasan nasal spray  1 0 0 
Innovage 1 0 0 
Lacidipine  0 0 1 
Lansoprazole 0 0 2 
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Lantus  0 0 2 
Lasicpnate 0 1 0 
Levothyroxin 1 1 0 
Linsinopril 0 0 3 
Loperamide 0 0 1 
Lovastatin 1 0 0 
Metformin 0 0 9 
Morphine 0 1 0 
Nicorandil  0 0 1 
Novarapid 0 0 1 
Omega 3 0 0 0 
Omeprazole  2 1 0 
Oramorph  0 1 0 
Paracetamol  3 3 1 
Peridopril 1 0 0 
Pregabalin 0 0 1 
PRN 0 2 1 
Propanolol 0 1 0 
Protiglitazone 0 0 1 
Quinnine 0 0 1 
Ramipril   1 2 2 
Rosiavastat 0 1 0 
Salbutamol  0 1 0 
Serotide 0 1 0 
Simvastatin  2 0 3 
Sitagliptin 0 0 1 
Solifenacin  0 0 1 
Spironlactone 0 0 1 
Statins 0 0 1 
Steroids (anti insulinaemic) 1 0 0 
Tabphyn  1 0 0 
Thiamine 0 1 0 
Thyroxine 1 0 0 
Tramadol  1 1 4 
Trimacet 0 1 0 
Trimadal 0 1 0 
Valsartan 0 0 1 
Ventolin  0 1 1 
Vitamin B 1 1 0 
Vitamin B12 1 0 0 
Vitamin E 1 0 0 
Warfarin 1 0 1 
Xalatin 0 0 0 
Xatalant 0 1 1 
Zopicclone 1 0 0 
Zydol 0 0 1 
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2.2 Blood and muscle samples  
Participant’s blood samples were taken in an overnight fasted state at 8-9am during pre-
operative assessment on the day of elective hip arthroplasty surgery. Muscle biopsies were 
obtained from the gluteus maximus of sedentary lean, obese and T2D male and female 
patients during surgery. These skeletal muscle samples were frozen in liquid nitrogen cooled 
isopentane and stored in -80°C freezers at the Life Science Building of Liverpool John Moores 
University until analysis was performed. Frozen skeletal muscle samples were fixed to cork 
using Tissue-Tek® (Tissue-Tek® O.C.T. Compound, Sakura® Finetek, Europe, and Netherlands). 
Samples were then transferred to a cryostat (OTF5000, Bright Instruments, UK) which was set 
at -20°C to prevent the thawing of skeletal muscle. The thickness setting was adjusted to 5μm, 
and skeletal muscle was cut and collected on VWR™ Super Premium Microscope Slides (VRW™, 
Avantor®, International), using optimal angles and pressure to ensure that the cut section 
adhered to the slide without damage. The 5μm sections were inspected with a light microscope 
(Apex™ Microscopes, Brunel Microscopes Ltd, Wiltshire, England) using the 10X/0.25NA 
objective to ensure that accurate cross-sectional cuts were obtained and the cells maintained 
good architectural integrity without significant frost damage. 
2.3 Immunofluorescent controls  
Negative control samples were run for BODIPY and mouse monoclonal anti-OxPhos Complex 
IV (COXIV), for this the standard immunofluorescence microscopy sequence was performed 
and BOIPY and COXIV were excluded and replaced with PBS (Figure 2.1). This permitted the 
testing of any nonspecific staining that may occur and the prevention of confounded data.  
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Figure 2.1 BODPIY and COXIV controls. Images obtained using an inverted confocal fluorescent 
microscope (A) and a fluorescence microscope (B). Negative controls of BODIPY (A) and COXIV (B) show 
no positive stain ensuring that nonspecific staining is prevented. Scale bar = 25μm 
  
A B 
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2.4 Lipid immunofluorescent staining protocol  
Sections were fixed for one hour in 3.7% formaldehyde, followed by 3x30 second (s) washes in 
doubly-distilled water (ddH20). Slides were then permeabilised for five minutes (min) in 0.5% 
triton-X 100 (Sigma-Aldrich, Merck Group, UK), followed by 3x5 min washes in 1x phosphate 
buffered saline (PBS, 137mM sodium chloride, 3 mM potassium chloride, 8 mM sodium 
phosphate dibasic and 3mM potassium phosphate monobasic, pH 7.4). The muscle samples 
were then incubated in the appropriate primary antibodies in PBS for 45 min followed by 3x5 
min washes in PBS. The primary antibodies used were mouse anti myosin heavy chain I (MHCI) 
(A4.840, DSHB, Iowa, USA) to target type I fibres and rabbit anti myosin heavy chain IIA (MHC 
IIA) (N2.261, DSHB, Iowa, USA) targeting type IIa fibres, both antibodies were used at 1:100 
dilution in PBS. Subsequently, the samples were washed for 3x5min in PBS and stained using 
appropriately targeted Alexa Fluor® immunofluorescent secondary antibodies for 30min, 
followed by another 3x5min wash in PBS. Alexa Fluor® dyes are a group of negatively charged 
and hydrophilic fluorescent dyes which are frequently used in fluorescence microscopy, the 
respective laser excitation wavelength is stated in their labelling. The secondary antibodies 
used were goat anti-rabbit IgG1-405 to target MHCIIA N2.261, goat anti-mouse IgM-546 
targeting MHCI A4.840 (Thermo Fisher, UK) both 1:200 dilution in PBS.  To stain the cell 
borders, wheat germ agglutinin-633 (WGA-633) (Sigma-Aldrich, Merck Group, UK) 1:50 
dilution was added to the 2ry AB. WGA is a lectin which binds to glycoproteins of the cell 
membrane. Subsequent to the final 3x5 min wash in PBS, samples were incubated for 20 min 
in BODIPY 493/503 (Sigma-Aldrich, Merck Group, UK) which was used at 1:100 dilution in PBS, 
followed by 1x5min wash in PBS. Finally, vectashield (Vector Laboratories, Burlingame, CA 
94010) was applied to the slides and mounted with VWR™ coverslips (VRW™, Avantor®, 
International) and sealed using transparent nail varnish.  
 
2.5 Confocal image acquisition – Lipid droplet imaging 
Images of the sections were obtained using an inverted confocal fluorescent microscope (Zeiss 
LSM710; Carl Zeiss AG, Oberkochen, Germany). A 63x 1.4NA oil immersion objective combined 
with 1.1 digital magnification was used to identify LDs in single cell field of view, for an example 
of this field of view see figure 2.1. Zeiss immersion oil was applied to the objective and slides 
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positioned in an inverted position. In accordance with the fluorescent staining methods used, 
sections were visualised with an argon laser which excited the Alexa Fluor 488 fluorophore and 
bodipy 493/503, whilst Alexa Fluor 546 and 633 fluorophores were excited with a helium-neon 
laser and Alexa Fluor 405 fluorophore excited with a diode laser. Fibres that stained positively 
for MHCI were categorised as type I fibres, whereas fibres that stained positively for MHC IIA 
were categorised as type IIa fibres and those that had no staining were categorised as type IIx 
fibres. To analyse a similar proportion of images in every individual sample an average of 15 
type I and 15 type IIa fibres were captured, resulting in a similar portion of fibres being analysed 
for each group (n=8) i.e. (15 x 8) 120 type I fibres; 120 type II fibres). Due to limited number of 
type IIx fibres in muscle sections in a number of participants, an average of 4 images were 
captured from every individual sample investigated (4 x 8) 32 type IIx fibres).  
2.6 Lipid imaging processing and analysis  
Confocal images obtained via the RGB channels were converted from LSM to TIFF image format 
prior to image analysis, through Zeiss Zen Blue software. Subsequently, images captured via 
the 633 laser were processed using Zen Black software and converted from LSM to TIFF format 
ready for analysis. Image analysis was completed using Image-Pro Plus, version 5.1 software 
(Media Cybernetics, Bethesda, MD, USA). Fibres were separated into a peripheral region (5 μm 
below cell membrane) and central region (remainder of the cell) to assess LD stores within 
each muscle fibre. The peripheral region was set at 5 μm due to previous research which 
suggest that 5 μm is representative of the subsarcolemmal region which would normally be 
detected using TEM (Koh et al., 2017; Strauss et al., 2020). To produce the peripheral region 
mask, an erosion mask of 5μm was applied from the cell border, the peripheral erosion mask 
was then inverted to create a mask for the central region of the fibre. The erosion masks were 
applied to greyscale images of LD to produce extracted images of LS in the peripheral and 
central region of the fibres (Figure 2.1). To identify LDs, an intensity threshold was uniformly 
selected and applied to each image obtained from the lean, obese and T2D participants. 
Intensity and threshold was also set for the area of LDs which represented the maximum and 
minimum limits which would represent a LD. From the images, LD content (% area stained), LD 
density (number of LDs expressed relative to the area) and LD size (mean area of an individual 
LD) within both the central and peripheral regions of each fibre type was investigated. LD 
content and LD density data obtained from analysis was normalised for the area of the region 
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prior to statistical analysis. Normalising the data ensured that the peripheral and central 
regions were made equal for comparison due to the central region encompassing a larger area 
compared to the peripheral region. Data obtained from LD size analysis was not normalised as 
it represents the mean area of an individual LD only and is not dependent on the area of the 
cell.  
0 
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Figure 2.2 LD image analysis method identifying the central and peripheral regions within cross-sectional 
muscle fibres. Images of LD for content analysis obtained using a 63x 1.4NA confocal microscope at 1.1 
zoom. Grey scale images of the cell border were identified with WGA mask (A). Processed grey scale 
images of LD stained with BODIPY 493/503 (D). Erosion mask of 5μm applied from the cell border to 
produce a peripheral region mask (B). Peripheral erosion mask inverted to create a mask for the central 
region of the cell (C). Masks B and C were applied to greyscale image of LD to produce extracted images 
of LD in the peripheral region of the cell (E) and the central region of the cell (F). ‘Region of interest’ 
(green line) was manually drawn around central region of the cell to exclude LD from neighbouring cells 
(F). Scale bar = 25μm 
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2.7 Mitochondria immunofluorescence staining protocol  
The current immunofluorescence staining protocol for mitochondrial density was developed 
in a previous study (Shaw et al., 2008).  The authors reported that using an antibody against 
the mitochondrial protein, cytochrome c oxidase (COX), may prove more favourable when 
examining fibre-type differences in mitochondrial density (Shaw, Jones and Wagenmakers, 
2008). Specifically, the anti-COX staining ((mouse monoclonal anti-OxPhos Complex IV (COXIV)) 
produced greater fluorescent signal and enhanced resolution of the mitochondrial network 
compared to other mitochondrial markers; mouse monoclonal anti-porin and mouse 
monoclonal anti-OxPhos Complex I. Furthermore, COXIV was successfully combined with MHCI 
(A4.840), an antibody used against type I fibre myosin (Shaw, Jones and Wagenmakers, 2008). 
Briefly, sections were fixed for one hour in 3.7% formaldehyde. The slides were then 
permeabilised in 0.5% triton-X 100 for five minutes, followed by 3x5 min washes in PBS. The 
primary antibody applied to the muscle samples contained COXIV (459600; Invitrogen, Paisley, 
UK) antibody 1:50 dilution used to label mitochondria, and MHCI (A4.840, DSHB, Iowa, USA) 
and MHCII (N2.261, DSHB, Iowa, USA) both 1:100 dilution in PBS. The 45 min incubation period 
was followed by 3x5 min washes in PBS. Samples were again incubated in appropriate 
secondary antibodies for 30 min followed by 3x5 min washes in PBS. The secondary antibodies 
conjugates used were goat anti-mouse IgG2a-488, goat anti-mouse IgM-546 and goat anti-
mouse IgG-350 (Thermo Fisher, UK) all 1:100 dilution in PBS, the secondary antibodies are used 
to target the primary antibodies. Furthermore, the cell border was stained with WGA-633 
(Sigma-Aldrich, UK) 1:50 dilution.  Mowiol® (Sigma-Aldrich Company Ltd, Dorset, UK) was 
applied to the slides and prepared using 6g Glycerol, 2.4g Mowiol, 6ml ddH2O, and 0.026g 
DABCO. Finally, VWR™ coverslips were mounted onto the sections (VWR™, Avantor®, 
International). 
2.8 Fluorescence microscope – Mitochondria imaging 
Microscopy images were obtained using a Leica DMB 6000 fluorescence microscope (Leica, 
Germany, Europe) with a 40x objective capturing ~5 cells in each image. Slides were placed in 
an inverted position above the objective. Similar to LD imaging process, fibres that stained 
positively for MHCI were categorised as type I fibres, whereas fibres that were not MHCI 
positive were categorised as type II fibres. Thirty images were acquired from each muscle 
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section to ensure that a similar quantity of images were analysed from all participants in all 
groups. An average of 183 type I fibres and 85 type II fibres were collected for analysis per 
participant.  
2.9 Mitochondria imaging processing and analysis  
Image processing was undertaken using Image-Pro Plus 5.1 software. Fibre-type distribution 
of mitochondria was assessed using wide-field images. Mitochondrial density was measured 
through the protein expression of COXIV, the fluorescence staining intensity of COXIV was used 
to indicate differences in mitochondrial density across fibre-types. Fluorescence intensity of 
COXIV was quantified by measuring the signal intensity within the intracellular regions of a 
mask created by the WGA-633 stain in a fibre-type specific manner (Figure 2.3).  
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Figure 2.3 Mitochondria image analysis method identifying fibre types within cross-sectional muscle 
fibres. Grey scale images of the cell border identified with WGA (A) and of mitochondria stained with 
COXIV (B). Fibres stained positively for MHCI identified as type I fibres and selected for analysis (C). All 
other fibres that did not stain positively for MHCI categorised as type II fibres and selected for analysis 
(D). Scale bar = 25μm. 
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2.10 Statistical analysis 
Statistical significance was set at P < 0.05. All data is expressed as means ± standard error of 
the mean (SEM). A t test was used to measure HOMA-IR and plasma differences within health 
groups between sex (example; lean male vs. female). Furthermore a two-way between-
subjects ANOVA was used to measure HOMA-IR and plasma differences between health 
groups within sex (example; obese males vs. Lean males vs. T2D males). A one-way between-
subjects ANOVA was used to measure the difference in LD profile (content, density and size) 
between sexes or health groups, the within subjects factors were identified as ‘fibre type’ and 
‘regions’ (sexes + fibre type; sexes + region; health groups + fibre type; health groups + region). 
A two-way within-subjects ANOVA was performed to measure the difference in LD profile 
within sex or health group, the within subjects factors were identified as ‘fibre type’ and 
‘regions’ (sex + fibre type; sex + region; health + fibre type; health + region). A four-way 
between-subjects ANOVA was implemented to determine significant differences in LD profile 
between sexes and health groups, factors were identified as ‘fibre type’ and ‘regions’.  (Sexes 
+ health groups + fibre + region). A four-way within-subjects ANOVA was used to determine 
significant differences in LD profile within sex and health group, factors were identified as ‘fibre 
type’ and ‘regions’ (sex + health + fibre type + region). To determine significant differences in 
the males and females mitochondrial density across all three health groups and both fibre 
types a three-way ANOVA was used. Significant main effects or interactions were assessed 
using Bonferroni adjustment post hoc analysis. Analysis was completed using SPSS statistical 
analysis software (v.26.0; SPSS, Chicago, IL, USA). 
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3. Results  
3.1 Sex differences in skeletal muscle lipid droplet profile 
3.1.1 Lipid droplet stores in males and females follow a hierarchical distribution across fibre-
types in both the peripheral and central regions 
LD content (expressed as % area stained) within the males followed a hierarchical distribution 
across fibre-types in both the peripheral (5μm band beneath the cell border) and central 
(remainder of the cell) regions of the cell, such that the LD content in the type I fibres > type 
IIa fibres > type IIx fibres (Sex x fibre x region interaction; P < 0.001; Fig 3.1A, B, C, Table 3.1). This 
was primarily driven through a similar hierarchical distribution in LD density across fibre-types 
(TI > TIIa > TIIx) within the peripheral and central regions of the muscle fibres (Sex x fibre x 
region interaction; P < 0.001; Fig 3.1D, E, F, Table 3.1), but not LD size (P > 0.05). Furthermore, 
similar patterns in fibre-type specific LD distribution and subcellular location were observed in 
the females for LD density (sex x fibre x region interaction; P < 0.05; Fig 3.1D, E, F, Table 3.1), but 
not for LD content (P > 0.05) or size (P > 0.05). For imagery representation see; Fig 3.4. 
3.1.2 Greater lipid droplet stores in the central vs peripheral region across all fibre-types in 
males and females 
The subcellular distribution of LDs differed when separating the cell into peripheral and central 
regions. When normalised for area (see 2.5), analysis revealed that LD content in the men was 
greater in the central regions when compared to the peripheral regions, and this pattern in LD 
subcellular location was true across all fibre-types investigated (Sex x region x fibre interaction; 
P < 0.001; Fig 3.1A, B, C, Table 3.1). This was largely due to greater LD density in the central region 
of the type I, IIa and IIx fibres in comparison to the peripheral region in males (Sex x region x 
fibre interaction; P < 0.001; Fig 3.1D, E, F, Table 3.1). Furthermore, in males, the type I and IIa 
fibres central region contained significantly larger LDs compared to the peripheral region (Sex 
x region x fibre interaction; P < 0.05; Fig 3.1G, H, Table 3.1). LD content in the females also 
followed a similar pattern in subcellular location (central > peripheral) within the type I and IIa 
fibres (Sex x region x fibre interaction; P < 0.05; Fig 3.1A, B, Table 3.1). This was driven through 
greater LD density in the central region of the type I, IIa and IIx fibres in comparison to the 
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peripheral region (Sex x region x fibre interaction; P < 0.05; Fig 3.1D, E, F, Table 3.1), and not size 
(P > 0.05). (Fig 3.4). 
3.1.3 Males exhibit greater lipid droplet stores across all fibre-types in the peripheral and central 
regions when compared to females 
Within the central region across all fibre-types, LD content was significantly greater in the men 
when compared the women (sex x region x fibre interaction; P < 0.05; Fig 3.1A, B, C, Table 3.1). 
These centrally located fibre-type differences in LD content found in males vs. females was 
mainly attributed to larger LDs (sex x region x fibre interaction; P < 0.05; Fig 3.1G, H, I, Table 3.1). 
Additionally, greater LD density was found in the central region of type I and IIa fibres of the 
males in comparison to the females (sex x region x fibre interaction; P < 0.001; Fig 3.1D, E, Table 
3.1). Whilst LD profile across all fibre-types in the central region was uniform in the males, this 
was not the case for the peripheral region. Sex differences in LD content and morphology 
within the peripheral region were mainly observed in the type I and IIa fibres (P < 0.05), and 
not the type IIx fibre (P > 0.05). Males indeed had greater LD content at the periphery of the 
type I and IIa fibres when compared to females (sex x region x fibre interaction; P < 0.05; Fig 
3.1A, B, Table 3.1), predominately due to larger LDs (sex x region x fibre interaction; P < 0.05; 
Fig 3.1G, H, Table 3.1) and a greater LD density in the type I fibres only (sex x region x fibre 
interaction; P < 0.05; Fig 3.1D, Table 3.1). (Fig 3.4). 
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Table 3.1 Lipid droplet profile in males and females 
 
 
 
 
 
 
 
 
 
 
 
 
Data provided as means ± SE. Lipid droplet (LD) content and density are expressed relative to the area 
of the peripheral or central region.  Within sex x fibre x region interaction type I > IIa > IIx fibres (P < 
0.05). † Within sex x region x fibre interaction central > peripheral (P < 0.05). ‡ Between sex x region x 
fibre interaction males > females (P < 0.05). 
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Fig. 3.1. Fibre-type and subcellular-specific changes in lipid droplet (LD) profile in male and female skeletal 
muscle. Presented are LD content (A, B, C), LD density (D, E, F), and LD size (G, H, I) in the peripheral 
and central subcellular regions of type I, IIa and IIx fibres. LD content and LD density in each region was 
normalized to total cell area.  Within sex x fibre x region interaction type I > IIa > IIx fibres (P < 0.05). † 
Within sex x region x fibre interaction central > peripheral (P <0.05). ‡ Between sex x region x fibre 
interaction males > females (P < 0.05). Values are means ± SE. 
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3.2 Differences in lean, obese and T2D participants skeletal muscle lipid droplet profile  
3.2.1. Lipid droplet content and density in lean, obese and T2D participants follow a hierarchical 
distribution across fibre-types in both the peripheral and central regions 
T2D and obese participants had greater LD content in the peripheral region of the type I > type 
IIx fibres and in the type IIa > type IIx fibres (health x fibre x region interaction; P < 0.05; Fig 
3.2A, B, C, Table 3.2). These differences in LD content were influenced by a similar distribution 
of LD density observed within the peripheral region of the fibres (health x fibre x region 
interaction; P < 0.05; Fig 3.2D, E, F, Table 3.2), but not LD size (P > 0.05). No differences in LD 
profile were found within the peripheral region of the skeletal muscle fibres of the lean 
participants (P > 0.05). Similarly, these patterns in fibre-type differences were observed in the 
central region of the lean, obese and T2D participants fibres (health x fibre x region interaction; 
content; P < 0.05, density; P < 0.05; Fig 3.2A-F, Table 3.2), again no changes were found in LD 
size (P > 0.05). Additionally, the patterns in LD content and density were also observed in the 
central region of the type I fibres > type IIa fibres in T2D and obese participants, thus following 
a hierarchical distribution across fibre-types (health x fibre x region interaction; content; P < 
0.05; density; P < 0.001; Fig 3.2A, D, Table 3.2). (Fig 3.4). 
3.2.2 Greater lipid droplet content and density in the central vs peripheral region across all fibre-
types in skeletal muscle from lean, obese and T2D participants 
In lean, obese and T2D, the central region had greater LD content in comparison to the 
peripheral region across all three fibre-types examined (health x region x fibre interaction; P < 
0.05; Fig 3.2A, B, C, Table 3.2), as a result of augmented LD density in the central region across 
the fibres (health x region x fibre interaction; P < 0.05; Fig 3.2D, E, F, Table 3.2) but no differences 
were shown for LD size (P > 0.05). (Fig 3.4). 
3.2.3 T2D participants have greater LD stores specifically in type IIa fibres compared to lean and 
obese participants 
In T2D participants the central region of type IIa fibres contained greater LD content when 
compared to the lean participants (health x region x fibre interaction; P < 0.05; Fig 3.2B, Table 
3.2). Interestingly no changes were observed in LD density or size between the T2D and lean 
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participants (P > 0.05). Furthermore, in T2D the peripheral region of the type IIa fibres had 
larger LDs in comparison to the obese participants (health x region x fibre interaction; P < 0.05; 
Fig 3.2H, table 3.2), with no differences in LD content or density (P > 0.05). (Fig 3.4). 
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Table 3.2 Lipid droplet profile in lean, obese and T2D participants 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data provided as means ± SE. LD content and density are expressed relative to the area of the peripheral 
or central region.  Health x fibre x region interaction type I > IIa > IIx fibres (P < 0.05). † Health x region 
x fibre interaction central > peripheral (P < 0.05). ‡ Between health x region x fibre interaction T2D > 
obese and lean (P < 0.05). 
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Fig. 3.2. Fibre-type and subcellular-specific changes in LD profile in skeletal muscle biopsies from lean, 
obese and T2D participants. Presented are LD content (A, B, C), LD density (D, E, F), and LD size (G, H, I) 
in the peripheral and central subcellular regions of type I, IIa and IIx fibres. LD content and LD density 
in each region was normalized to total cell area. * Within health x fibre x region interaction type I > IIa 
> IIx fibres (P < 0.001). † Within health x region x fibre interaction central > peripheral (P < 0.05). ‡ 
Between health x region x fibre interaction T2D > obese and lean (P < 0.05). Values are means ± SE. 
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3.3 Differences in skeletal muscle lipid droplet profile between lean, obese and T2D males and 
females  
3.3.1 T2D males have greater lipid droplet stores within the central region of type IIa fibres 
compared to lean and obese males 
The central region of the type IIa fibres in T2D males contained greater LD content when 
compared to the obese and lean males (health x sex x fibre x region interaction; P < 0.05; Fig 
3.3A, table 3.3). These differences in LD content were driven through larger LDs (health x sex x 
fibre x region interaction; P < 0.05; Fig 3.3C, table 3.3), but not LD density (P > 0.05). 
Additionally, no differences were observed in fibre-type or subcellular location of LD content, 
density or size between the lean, obese and T2D females (P > 0.05). (Fig 3.4). 
3.3.2 Lean males have greater LD content within the central region of type IIa and IIx fibres 
compared to lean females 
Lean males have greater LD content within the central region of their type IIa and IIx fibres in 
comparison to lean women (sex x health x fibre x region interaction; P < 0.05A; Fig 3.3, table 
3.3). Attributed to larger LD in the type IIa fibres (sex x health x fibre x region interaction; P < 
0.05; Fig 3.3C, table 3.3) but not LD density (P > 0.05). No differences were observed in lean 
males and females within the peripheral region of the muscle fibres (P > 0.05). (Fig 3.4). 
3.3.3 Obese males have greater LD stores within the central regions of the type I and IIa fibres 
when compared to obese females 
Obese men had greater LD content within the central region of their type I and IIa fibres in 
comparison to obese women (sex x health x fibre x region interaction; P < 0.05; Fig 3.3A, table 
3.3). This was due to both larger LDs (sex x health x fibre x region interaction; P < 0.05; Fig 3.3C, 
table 3.3) and greater LD density (sex x health x fibre x region interaction; P < 0.05; Fig 3.3B, 
table 3.3). Furthermore, the peripheral region of type I fibres in obese males contained greater 
LD density when compared to obese females (P < 0.05; Fig 3.3B, table 3.3) with no differences 
shown in LD content or LD size (P > 0.05). (Fig 3.4). 
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3.3.4 T2D male have greater LD stores within the peripheral and central regions of type I, IIa 
and IIx fibres in comparison to T2D females 
In T2D men, both the peripheral and central regions of their type I and type IIa fibres contained 
greater LD content in comparison to the women (sex x health x fibre x region interaction; P < 
0.05; Fig 3.3A, table 3.3). Furthermore, the central region of the type IIx fibres of T2D men had 
greater LD content compared to the women (sex x health x fibre x region interaction; P < 0.05; 
Fig 3.3A, table 3.3). These fibre-type and subcellular differences in LD content were primarily 
driven through larger LDs (sex x health x fibre x region interaction; P < 0.05; Fig 3.3C, table 3.3). 
Additionally, in T2D males, the peripheral region of the type IIa fibres had augmented LD 
density compared to the T2D women (sex x health x fibre x region interaction; P < 0.05; Fig 
3.3B, table 3.3). (Fig 3.4). 
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Table 3.3 Lipid droplet profile in skeletal muscle of lean, obese and T2D males and females 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data provided as means ± SE. LD content and density are expressed relative to the area of the peripheral or central region.  Health x sex x fibre x region 
interaction T2D men > obese and lean males (P < 0.05). † Sex x health x region x fibre interaction males > females (P < 0.05).  
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Fig. 3.3. Fibre-type and subcellular-specific changes in LD profile in skeletal muscle biopsies from lean, 
obese and T2D males and females. Presented are LD content (A), LD density (B), and LD size (C) in the 
peripheral and central subcellular regions of type I, IIa and IIx fibres. LD content and LD density in each 
region was normalized to total cell area. * Between health x within sex x fibre x region interaction T2D 
men > obese and lean males (P < 0.05). † Between sex x within health x fibre x region interaction males 
> females (P < 0.05). Values are means ± SE. 
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Fig.3.4.a. Greyscale images of fibre type specific immunofluorescence staining of LDs in the skeletal muscle of lean, obese and T2D males and females. 
Representative greyscale images of LDs stained using BODIPY 493/503 within different fibre-types obtained using immunofluorescent confocal microscopy with a 63x oil 
immersion objective and 1.1 digital zoom. The left panel includes representative images obtained from the male participants and the right panel images from the female 
participants. The top line signifies images obtained from lean participants, the middle; obese participants and the bottom; T2D participants. 
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Fig.3.4.b. Merged images of fibre type specific immunofluorescence staining of LDs in the skeletal muscle of lean, obese and T2D males and females. 
Representative merged images of LDs (green), cell border stained using WGA-633 (pink) within different fibre-types obtained using immunofluorescent confocal microscopy 
with a 63x oil immersion objective and 1.1 digital zoom. The left panel includes representative images obtained from the male participants and the right panel images from the 
female participants. The top line signifies images obtained from lean participants, the middle; obese participants and the bottom; T2D participants. Positive MHC I signal (red) 
are type I fibres, MHC IIa (blue) are type IIa fibres. Fibres that showed no stain were categorised as type IIx.  Scale bars represent 25 µm. 
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3.4 Differences in mitochondrial density are predominately fibre-type driven, and not determined 
by sex or metabolic health  
Mitochondrial density (determined using COXIV expression) followed a hierarchical 
distribution across fibre-types, such that the mitochondrial density in the type I fibres (39.14 ± 
2.98 μm2) > type II fibres (26.87 ± 2.39 μm2) (main effect of fibre; P < 0.001; Fig 3.5, table 3.4). 
This fibre-type distribution also remained true when mitochondrial density was determined in 
both the males and females (sex x fibre interaction; P < 0.001; Fig 3.5, table 3.4). Additionally, 
these patterns in fibre-type distribution were also observed within the lean, obese and T2D 
participants (health x fibre interaction; P < 0.001; Fig 3.5, table 3.4). There were no differences 
observed between the sexes or the lean, obese and T2D skeletal muscle biopsies mitochondrial 
density (P > 0.05; Fig 3.5, table 3.4). (Fig 3.6). 
  
68 
 
Table 3.4 Mitochondrial density in skeletal muscle of lean, obese and T2D males and females 
 
 
 
 
 
 
 
 
 
 
Data provided as means ± SE.  Main effect of fibre-type; type I > type II (P < 0.001). † Sex x fibre 
interaction; type I > type II in males and females (P < 0.001). ‡ Health x fibre interaction; type I > type II 
in lean, obese and T2D (P < 0.001). 
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Fig. 3.5. Fibre-type changes in mitochondrial density in skeletal muscle from lean, obese and T2D males 
and females. Values are means ± SE. Mitochondrial density significantly greater in type I vs. type IIa 
fibres in men and women (P < 0.001). †Mitochondrial density significantly greater in type I vs. type IIa 
fibres in lean, obese and T2D participants (P < 0. 001). 
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Fig 3.6. Fibre type specific immunofluorescence staining of mitochondria in the skeletal muscle of lean, obese and T2D males and females. 
Representative images of mitochondrial density stained using COX (green) within different fibre-types obtained using wide field fluorescent microscopy. Images 
were captured using a 40x objective.  Cell border was stained using WGA-633 (pink). The left panel includes representative images obtained from male 
participants and the right panel images from female participants. The top line signifies images obtained from lean participants, the middle; obese participants 
and the bottom; T2D participants. Corresponding fibre-type staining for each image is also shown; positive MHC I signal (red) were categorised as type I fibres, 
any fibres without a positive MHC I stain were categorised as type II fibres.  Scale bars represent 25 µm.  
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4. Discussion  
4.1 Overview 
A Western lifestyle, typically characterised by a reduction in physical activity, increased 
sedentary behaviour and overindulgence in energy rich food, has contributed to the current 
global obesity epidemic and increased prevalence of T2D (World Health Organisation, 2017; 
Diabetes UK, 2019). As a result of this, several studies have investigated the impaired buffering 
capabilities of adipose tissue which results in a lipid overspill into peripheral metabolic tissues 
(Frayn, 2002b), and have aimed to identify the mechanisms by which abnormalities in lipid 
metabolism lead to insulin resistance. To date, most of the research within this area has almost 
exclusively been completed in cohorts of young healthy males (Strauss et al., 2016; Shepherd 
et al., 2017; Gemmink et al., 2018). This is a considerable oversight considering females make 
up ~50% of the population and typically display greater insulin sensitivity when compared to 
BMI-matched males (Geer and Shen, 2009).  Females appear to have better protective 
physiological mechanisms against metabolic diseases than their male counterparts (Groban et 
al., 2016). Furthermore, the studies that have investigated females tend to only include pre-
menopausal women with normal levels of the female sex hormones (Tarnopolsky et al., 2007). 
Finally, the fibre-type and region-specific differences in LD distribution and morphology across 
a range of metabolic health statuses have not yet been investigated. Such data could generate 
the currently missing understanding of the role played by LD morphology in the inborn 
presence of a higher insulin action in females than males. 
An important factor in the development of insulin resistance is impaired IMTG turnover in 
skeletal muscle (Moro 2007, Shaw 2010). The accumulation of deleterious FA metabolites that 
lead to insulin resistance in obese individuals and T2D patients are intrinsically linked to a 
decreased ability to utilise IMTG stores during exercise (Amati et al., 2011a). Previous research 
demonstrates an association between elevated IMTG content and the development of insulin 
resistance in this population (Goodpaster et al., 2000; Goodpaster et al., 2001). However, more 
recent findings indicate a more complex relationship between IMTG content and insulin 
sensitivity (Amati et al., 2011a; Bilet et al., 2020). This complex relationship requires further 
investigation to establish a better understanding of the mechanisms underpinning to lipid-
72 
 
induced insulin resistance. The present study aimed to use validated immunofluorescence 
microscopy methods (Shepherd et al., 2012; Shepherd et al., 2013b; Shepherd et al., 2017) to 
identify sex differences in older individuals (with or without obesity and/or T2D) in the fibre 
type and subcellular (region-specific) LD profile and mitochondrial content in human skeletal 
muscle. A primary novel finding of the present study is that males have significantly greater LD 
content compared to females (Fig 3.1), due to a combination of a greater LD density and size. 
However, no significant differences were found in mitochondrial density between males and 
females (Figure 3.5). Another major novel finding was the increased size of LD specifically in 
the type IIa fibres of males with T2D compared to lean and obese males (Figure 3.3). 
4.2 Confocal immunofluorescence microscopy  
Extensive research has been conducted investigating differences in IMTG stores, and the 
predominant method adopted to achieve this originally were lipid extraction methods from 
homogenised whole homogenates (Watt et al., 2002; Bergman et al., 2010). Key limitations of 
this analysis technique are that between-biopsy variability is considerably high (23%) (Watt, 
Heigenhauser and Spriet, 2002). In addition homogenisation of the muscle makes it impossible 
to measure differences between fibre types and their capacity to store IMTG after exercise and 
utilise IMTG during exercise. This is an important oversight when it is considered that type I 
fibres have an enhanced capacity to store IMTG whilst remaining more insulin sensitive than 
type II fibres (van Loon and Goodpaster, 2006; Shepherd et al., 2013b). These findings are 
paramount in the development of knowledge surrounding the relationship between LD and 
insulin sensitivity. Nevertheless, studies have shown greater IMTG stores in type I skeletal 
muscle fibres corresponding with a higher oxidative capacity in type I fibres compared to other 
fibre-types (Malenfant et al., 2001; He, Goodpaster and Kelley, 2004; Shepherd et al., 2017; 
Whytock et al., 2020). Previous findings also propose that LD located in the subsarcolemmal 
region of skeletal muscle fibres are associated with insulin resistance compared to those 
located in the intermyofibrillar (IMF) region (Gemmink et al., 2017; Daemen et al., 2018). Based 
on this collective knowledge, the current thesis adopted a fibre-type (TI vs TIIa vs TIIx) and 
region-specific (peripheral vs central) approach to investigate differences in LD content, 
morphology (LD size and density) and distribution. As anticipated, our data showed fibre-type 
and region-specific differences in the LD profile. Overall, the greater LD content in the type I 
fibres compared to the type IIa and IIx fibres was driven through an increased LD density rather 
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than a difference in LD size (Fig 3.1-3). This observation of a hierarchical LD distribution 
between the different fibre types is in line with previous literature (Whytock et al., 2020). 
Characteristically, type I fibres have greater mitochondrial content which, paired with an 
abundance of lipolytic regulatory proteins (Shaw et al., 2020), results in an enhanced ability to 
store and utilise IMTG in type I fibres compared to type IIa and IIx fibres. In line with previous 
findings, the current study found that the central region of the skeletal muscle fibres contained 
greater LD content compared to the peripheral region, and similar to the fibre type data, this 
greater LD content in this region was due to an increased LD density (Fig 3.1-3). It is proposed 
that the turnover of centrally located LDs is greater due to the increased capacity of the central 
region to utilise IMTG during exercise as they are located near the IMF mitochondria 
(Tarnopolsky et al., 2007; Shaw, Jones and Wagenmakers, 2008). These results emphasise the 
importance of research adopting fibre-type and region-specific approaches when examining 
LD distribution and morphology.  
4.3 Sex differences in human skeletal muscle lipid droplet profile  
This study was the first to directly investigate and compare sex differences in LD profile within 
an older population (>60 years). In contrast to the hypothesis, male participants exhibited 
greater LD content compared to females, which was driven through greater LD density and 
larger LDs within both the central and peripheral regions of all three fibre types (Fig 3.1). These 
patterns of fibre type and region-specific distribution and morphology of LDs are the first of 
their kind within these groups, thereby highlighting the importance of investigating sex 
differences in older populations. 
A consensus is yet to be reached on whether sex differences exist in the LD profile, which is 
due to the lack of well-controlled studies that have included female participants.  Nevertheless, 
previous findings have proposed that females are more likely to exhibit greater LD stores 
compared to their BMI-matched male counterparts (Haugaard et al., 2009), which is in contrast 
to the findings of this study. Importantly, the previous findings were predominantly obtained 
within younger pre-menopausal female populations (Tarnopolsky et al., 2007; Haugaard et al., 
2009; Link and Reue, 2017). To add context to these findings, younger pre-menopausal women 
have normal levels (fluctuations) of oestrogen and progesterone and appear to be better 
protected against metabolic diseases compared to men (Pérez-López et al., 2010). Conversely, 
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peri- and post- menopause, the production of female sex hormones diminishes leading to an 
increased risk of cardiometabolic syndrome, thus suggesting that the female sex hormones 
may act as a protective mechanism in pre-menopausal females (Polotsky and Polotsky, 2010). 
Oestrogen regulates various aspects of lipid metabolism; 17ß-ethinyl-estradial is the most 
potent oestrogen which exerts its physiological actions through oestrogen receptors; ER and 
ER (Lizcano and Guzmán, 2014). 17ß-ethinyl-estradial has been shown to prevent TG 
accumulation through suppression of LPL activity, whilst also increasing the expression of HSL 
resulting in increased lipolysis and improved lipid oxidation via augmented phosphorylation of 
AMPK. Furthermore, in skeletal muscle 17ß-ethinyl-estradial improved glucose disposal via 
modulation of the expression and trafficking of GLUT4 thus improving glucose clearance and 
enhancing insulin sensitivity (Jelenik and Roden, 2013). Disturbances in these metabolic signals 
caused by decreases in oestrogen levels and oestrogen receptor expression observed in post-
menopausal women may therefore lead to impaired lipid metabolism, in turn reducing IMTG 
turnover.  
Males also experience a decline in sex hormones during older age which has been suggested 
to negatively impact lipid metabolism and insulin signalling. The diminished testosterone levels 
associated with ageing in males may contribute to reduced metabolic action resulting in 
potential IMTG accumulation, ultimately increasing the risk of developing metabolic syndrome 
(Errazuriz et al., 2015; Link and Reue, 2017). Normal testosterone levels have been shown to 
increase lipolysis whilst decreasing LPL activity thus limiting TG accumulation. Furthermore, 
there is evidence that testosterone could increase insulin sensitivity by decreasing the levels 
of pro-inflammatory cytokines (IL-6 and TNF-) responsible for increased insulin resistance 
(Ottarsdottir et al., 2018). Previous research has also shown a positive correlation between 
genetic (e.g. OXPHOS gene expression) and functional (VO2max) markers of mitochondrial 
function and testosterone levels (Pitteloud et al., 2005). This suggests that testosterone may 
play an important role in modulating molecular mechanisms such as mitochondrial function. 
Therefore, the accumulation of LDs shown in males in the current study could also be 
attributed to reduced mitochondrial function resulting from an age-related decline in 
testosterone.  Overall, it is possible that the sex differences observed in the current study (in 
comparison to previous studies comparing sex) are, at least in part, due to the older age of the 
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participants investigated, and that the age-related decline in testosterone could be a potent 
stimulus for IMTG accumulation.  
Research has previously proposed that a greater density (number) of small LDs may be 
metabolically advantageous compared to a smaller number of larger LDs, due to the greater 
LD surface area for lipases and protein binding, thereby improving the capacity for lipolysis and 
the release of FA to supply to the mitochondria (Suzuki et al., 2011). The smaller LDs observed 
within the females compared to the males could suggest a greater capacity for IMTG utilisation 
in the females. These results are in line with previous research in younger females who are 
purported to have a greater capacity for IMTG utilisation (Roepstorff et al., 2002). These 
findings have suggested that the greater IMTG concentrations within female skeletal muscle is 
often coupled with higher plasma FA availability and a greater expression of FAT/CD36 
(Lundsgaard and Kiens, 2014). Furthermore, the ‘coat’ of female LDs has also proven 
favourable for increased protein accessibility, with females having greater PLIN2, 3 and 5 
protein expression compared to BMI matched males (Peters et al., 2012). Of these, PLIN3 is 
recognised as an important protein involved in LD lipolysis and PLIN5 in the regulation of ATGL 
action and more recently its role in mediating LD and mitochondria interactions (Granneman 
et al., 2011; Wang et al., 2011; Covington et al., 2014). Together, it is proposed that the smaller 
LDs and increased PLIN expression within females is likely to increase association with lipases 
and ultimately mitochondria thereby increasing IMTG turnover (Lundsgaard and Kiens, 2014). 
The current results support these assertions, and despite females showing lower IMTG levels 
in the present study, the differences in LD morphology between sexes does suggest that the 
female LD pool may be more metabolically flexible.  
Interestingly, the current results showed no difference in mitochondrial content between 
sexes. A question therefore emerges concerning a possible difference in the rate of IMTG 
turnover. Previous research suggests that sex does not influence mitochondrial morphometry 
((area (%) and number (μm2)) (Tarnopolsky et al., 2007), although females have shown 
enhanced mitochondrial quality in comparison to males (Cardinale et al., 2018). It is therefore 
proposed that enhanced fat oxidation often observed within females can, in part, be attributed 
to improved mitochondrial oxidative function as opposed to mitochondrial content alone.  
Nevertheless, the findings reporting sex differences in mitochondrial morphometry are 
primarily investigated within younger populations (Tarnopolsky et al., 2007; Cardinale et al., 
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2018). Aging notoriously induces declines in mitochondrial content concomitant with a 
reduction in oxidative capacity (Petersen et al., 2003; Crane et al., 2010). Together with the 
whole-body loss of muscle mass (sarcopenia) which naturally occurs with aging, complications 
in lipid metabolism are presented (Crane et al., 2010; Chee et al., 2016). Therefore, it could be 
that the current findings imply that females indeed have greater expression of PLINs and 
lipases (HSL and ATGL) which would support a greater turnover of the IMTG pool.  
Furthermore, it could also be proposed that the females have greater LD-mitochondria 
interactions, however the present study cannot confirm this from the current data gathered 
therefore future work should investigate this.  
4.4 Differences in older lean, obese and T2D participants skeletal muscle lipid droplet profile  
To our knowledge this study is the first of its kind to investigate differences in LD profile in 
older lean and obese individuals, with/without type 2 diabetes. In this context, comparisons 
have previously been made between groups that differ in metabolic health, but these studies 
are often confounded by differences in physical activity levels.  In the present study, all 
participants were sedentary due to their reduced mobility linked to the impending surgery. 
This provided a unique opportunity to investigate differences in the LD profile between groups 
with differing metabolic health but similar activity levels. Although HOMA-IR scores showed 
that all of our groups presented with a degree of insulin resistance and that the T2D 
participants were significantly more insulin resistant than the lean sedentary group (Table 3.2), 
minimal differences were observed between these groups and their LD profile (Fig 3.2).  
Using confocal immunofluorescence microscopy, differences in LD profile were observed 
primarily in the type IIa fibres of the T2D patients, whom showed a greater LD content 
compared to the lean group and larger LDs compared to the obese group (Fig 3.2). These 
findings are in agreement with previous observations which show T2D individuals primarily 
store larger LDs in type II fibres (Daemen et al., 2018). Furthermore, the larger LDs observed in 
T2D patients are suggested to be located within the subsarcolemmal region of the type II 
muscle fibres (Li et al., 2019). The current findings also suggest an accumulation of larger LD in 
the central region may prove deleterious, specifically within the type IIa muscle fibres as this 
was seen in T2D patients only. Larger LD have a smaller surface area to volume ratio compared 
to smaller LDs, in turn IMTG turnover is reduced resulting in an accumulation of deleterious 
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lipid metabolites (Amati et al., 2011a). Furthermore,  previous research proposes that larger 
LDs could also prove unfavourable due to reduce oxidative capacity by ‘hijacking’ 
synaptosomal-associated protein 23 (SNAP23) for LD fusion processes thus preventing GLUT-
4 storage vesicles from fusing and docking at the plasma membrane (Boström et al., 2007).  
The elevated IMTG content within the current T2D participants could also be a result of 
impaired expression of various proteins which assist in IMTG synthesis and breakdown 
(Morales, Bucarey and Espinosa, 2017b). FAT/CD36 appears to be involved in the regulation of 
FA oxidation within human skeletal muscle through its control/regulation of LCFA uptake into 
skeletal muscle (Holloway et al., 2007). However, in T2D individuals FAT/CD36 cycling between 
the plasma membrane and intracellular compartments is altered, due to a permeant relocation 
of CD36 to the plasma membrane FAT/CD36 cycling is increased thereby leading to an 
abnormal increase in the rate of LCFA transport into the skeletal muscle. Without altered LCFA 
oxidation to match the increased LCFA transport there is an inevitable excess accumulation of 
IMTG (Bonen et al., 2004; Aguer et al., 2011); this could be a possible explanation of IMTG 
accumulation shown within the current T2D participants. Interestingly Holloway et al. (2007) 
observed no differences in FAT/CD36 expression between lean and obese skeletal muscle, and 
suggested that the accumulation of IMTG content was a result of compromised lipid oxidation 
due to a decrease in mitochondrial content with significant decreases in in -HAD, citrate 
synthase (CS) activity and COX-IV content. Furthermore, reduced PLIN5 protein expression has 
also been reported within T2D skeletal muscle when compared to athletes (Daemen et al., 
2018; Daemen, van Polanen and Hesselink, 2018). PLIN5 plays a role in FA release for oxidative 
degradation in mitochondria (Bosma et al., 2012; Bosma et al., 2013), thereby acting as a 
protective mechanism which promotes the interaction of LDs with mitochondria in turn 
decreasing lipotoxicity (Gemmink et al., 2016). Additionally, PLIN5 is an important regulator of 
ATGL action which is decreased within T2D skeletal muscle (Daemen et al., 2018). ATGL is a key 
regulator of skeletal muscle lipolysis, and therefore reduced ATGL activity may play a role in 
decreased IMTG utilisation and ultimately lead to IMTG accumulation within T2D (Jocken et al., 
2010; Fujimoto and Parton, 2011). Conversely, Jocken et al. (2010) found that ATGL along with 
HSL protein expression was increased in obese individuals, however paired with lower DAG 
hydrolase activity implied that lipolysis is incomplete. Therefore, it is possible that these 
alterations in protein expression and enzyme activity previously reported in T2D patients are 
78 
 
possible factors contributing to the increased LD content within the T2D participants in the 
current study.  
Interestingly, no differences in mitochondrial density were observed between the lean, obese 
and T2D groups which could be due to similar levels of (in)activity between the participants 
whilst awaiting orthopaedic surgery. This is the first study to investigate these differences in 
mitochondrial density, LD content and morphology between groups with similar levels of 
inactivity, as previous research has primarily investigated these differences between physically 
active and sedentary groups (Tarnopolsky et al., 2007; Phielix et al., 2010; Cobley et al., 2012; 
Bilet et al., 2020). Consequently, the current study is the first to suggest that mitochondrial 
density is independent of metabolic health status, which contradicts previous findings. It has 
been suggested that augmented mitochondrial density leads to improved oxidative capacity 
thus allowing greater IMTG turnover, and this phenomenon has frequently been observed 
within physically active individuals (Karakelides et al., 2010). Additionally, skeletal muscle 
obtained from obese and T2D individuals characteristically has smaller, less dense 
mitochondria in the peripheral and central region of muscle fibres (Kelley et al., 2002). With 
no difference in mitochondrial density between groups, it could be that the quality and 
function of mitochondria plays a more extensive role in IMTG turnover rather than 
mitochondrial content alone. Furthermore, LD-mitochondrial interactions are also an 
important factor of IMTG turnover, with evidence of a more dispersed distribution of IMTG to  
mitochondria in sedentary individuals therefore IMTG turnover is often reduced (Haugaard et 
al., 2009). The athlete’s paradox highlights the importance of physical activity and lipid 
metabolism showing a phenomenon whereby trained individuals show elevated IMTG content 
yet remain highly insulin sensitive, however their abundance of mitochondria suggests regular 
IMTG turnover thus the risk of lipid metabolite accumulation is reduced (Goodpaster et al., 
2001; Amati et al., 2011a). Therefore, physical inactivity could be a primary determinant of 
IMTG accumulation predominately shown in older adults, partially driven by a 35-40% decline 
in skeletal muscle mitochondrial oxidative/phosphorylation activity (Petersen et al., 2003). 
Cobley et al. (2012) provide evidence that individuals following a lifelong endurance training 
regime are able to maintain mitochondrial content and skeletal muscle oxidative capacity.  This 
could also lead to lifelong improvements in IMTG turnover and skeletal muscle insulin 
sensitivity in older adults. Furthermore, research investigating the effects of physical inactivity 
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reported a ~22% decrease in mitochondrial oxidative capacity and skeletal muscle fat oxidative 
capacity in participants when comparing an active leg to a suspended leg, which had a direct 
impact on IMTG accumulation (Bilet et al., 2020). Overweight individuals have proven to 
benefit from regular exercise with evidence of reduced LD size and greater mitochondrial 
content adjacent to LD, leading to possible improvements in LD-mitochondrial interaction and 
increased IMTG turnover (He, Goodpaster and Kelley, 2004).  
4.5 Differences in skeletal muscle lipid droplet profile between lean, obese and T2D males and 
females  
Two novel findings were produced from the current thesis when directly comparing the lipid 
droplet profile of lean, obese and T2D men and women across fibre-types and within specific 
regions of the muscle fibres. Firstly, the lean, obese and T2D males exhibited greater LD 
content within the central and/or peripheral regions of the type I, IIa and IIx fibres driven 
through larger LDs and/or greater LD density in comparison to their BMI matched female 
counterparts (Fig 3.3). These LD characteristics have previously proven deleterious as an 
accumulation of larger LDs in skeletal muscle has been positively correlated with impaired 
insulin signalling (Li et al., 2019). Furthermore, LD accumulation within the peripheral region 
of the skeletal muscle fibres could be a possible contributing factor in the development of 
skeletal muscle insulin resistance due to the close proximity of LDs to the site of the insulin 
signalling cascade (Gemmink et al., 2017). In contrast, previous research that examined sex 
differences within an impaired metabolic health group observe greater IMTG stores, by 
twofold, in obese women compared to BMI-matched obese males (Haugaard et al., 2009). 
However, Haugaard et al. (2009) observed these differences within a younger population and 
within muscle biopsies obtained from the vastus lateralis.  It is possible that the variations in 
participant age and skeletal muscle samples are contributing factors in the differences 
observed between the current studies results and previous findings. Additionally, a sex 
difference has also been observed in IMTG content within sedentary participants, partially due 
to sex related differences in HSL activity in skeletal muscle (Roepstorff et al., 2006). It is thought 
that higher HSL expression in skeletal muscle leads to greater IMTG hydrolysis, this is further 
supported by previous results which indicate female skeletal muscle indeed has higher IMTG 
hydrolysis rates during exercise driven through improved IMTG and activated HSL interaction 
(Roepstorff et al., 2006). These findings alongside the current study could imply that the lower 
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LD content within the females is partially due to elevated HSL expression and greater IMTG 
hydrolysis. Additionally, a two-to-threefold greater LPL gene expression has previously been 
observed in sedentary women’s skeletal muscle compared to sedentary men, thus 
demonstrating potential for augmented muscular lipoprotein activity in females (Kiens et al., 
2004).  
Interestingly Perreault et al. (2010) found that alterations in IMTG metabolism related to 
diminished insulin action more so in men than women, leading to the progression of T2D. It is 
important to note that all participants within the current study had a HOMA-IR score above 2.9 
and were therefore classified as insulin resistant (Table 2.1). However, compared to their 
female counterparts, the lean and T2D males had significantly lower HOMA-IR scores, 
suggesting they were relatively less insulin resistant, yet they exhibited a greater LD content 
(Fig 3.3). This suggests that IMTG accumulation per se within older populations may not be 
related to insulin action. Rather, it is possible that sex and health differences in LD morphology 
and subcellular distribution of IMTG are more closely related to insulin action. Moreover, a 
question emerges regarding the absence of differences in mitochondrial density between the 
lean, obese and T2D males and females, alongside greater LD content within the male skeletal 
muscle.  It could be that the differences observed between the males and females LD profile 
and level of insulin resistance could be potential evidence of a sex paradox in older individuals. 
Together, these results are in line with previous findings which suggest that reductions in 
oestrogen in the females could be of greater consequence for health than the decreased 
testosterone expression in the males (Nyberg et al., 2014; Egelund et al., 2017; Mandrup et al., 
2017; Novella et al., 2019). Indeed, the current findings require further investigation to further 
understand the mechanisms behind this phenomenon whereby females have lower LD stores 
and greater HOMA-IR scores. 
The second novel finding is the greater LD content within the skeletal muscle of T2D males, 
specifically within the central region of their type IIa fibres, compared to obese and lean males, 
all of whom were sedentary (Fig 3.3). The differences observed in the T2D males resulted from 
larger LDs. It is possible that these differences in LD storage shown within the T2D males 
induces greater insulin resistance within these participants as shown in their HOMA-IR scores 
which are significantly higher compared to the lean males (Table 2.1). As discussed previously, 
a larger LD proves unfavourable for effective lipid turnover and insulin action (see 4.3). 
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Furthermore, the lower mitochondrial density shown within the type II fibres of the T2D males 
suggests a dysregulation of LD turnover (synthesis and lipolysis) resulting in the accumulation 
of larger LD (Daemen et al., 2018). Previous research also shows fragmented mitochondria 
specifically in type II muscle fibres due to obesity-induced insulin resistance and reduced 
physical activity, resulting in the accumulation of IMTG (Kristensen et al., 2018). Physical 
inactivity is often associated with reduced mitochondrial oxidative capacity in skeletal muscle, 
it is suggested that this is a major contributor in IMTG accumulation and subsequently insulin 
resistance (Bilet et al., 2020). Furthermore, previous findings indicate improvements in insulin 
resistance following exercise and weight loss due to reduced LD size and an increase in 
oxidative enzyme activity (He, Goodpaster and Kelley, 2004). These findings further support 
the hypothesis that it is not simply IMTG content per se that determines insulin resistance, but 
rather the morphology and distribution of stored LDs (He, Goodpaster and Kelley, 2004). 
Data from the present study suggests a similar relationship to the athlete’s paradox whereby 
inactivity alongside older age and sex may be more important determinants of insulin 
sensitivity than IMTG content alone. It is believed that aging is a determinant of IMTG 
accumulation and the development of insulin resistance. As discussed previously (see 4.3), 
ageing affects various physiological functions, more specifically sarcopenia which is the result 
of gradual skeletal muscle mass loss (Crane et al., 2010; Lang et al., 2010). Sarcopenia may 
induce severe metabolic dysfunction leading to increased insulin resistance and ultimately T2D 
(Gueugneau et al., 2015; Gueugneau et al., 2018). Additionally, reduced mitochondrial content 
is apparent within aged participants thus decreasing oxidative capacity. However the rate of 
decline in mitochondrial content is accelerated following a sedentary lifestyle (van Loon et al., 
2004; Peterson, Johannsen and Ravussin, 2012). These findings are in agreement with the 
present study which showed an augmented LD content within the central region of the type 
IIa muscle fibres of the T2D males possibly due to the combination of older age and physical 
inactivity, both major determinants in the accumulation of LDs. These findings are supported 
by previous literature, with further examination of the differences in IMTG content and 
distribution between skeletal muscle of older and young skeletal volunteers. Chee et al. (2016) 
observed no differences when comparing IMTG content in young lean and older lean 
participants; both presented similar IMTG content located within the subsarcolemmal region. 
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However, when these findings were compared to older, overweight participants IMTG content 
within the subsarcolemmal region was twofold higher.  
4.6 Strengths & Limitations  
A key strength of the current study is the use of validated immunofluorescent microscopy 
techniques to examine the fibre type and region-specific differences in LD profile between sex 
and metabolic health status. Consequently, these techniques have provided an insight into 
region specific differences in LD profile in different muscle fibres, further advancing current 
knowledge of IMTG stores. Furthermore, the older population investigated has proven 
invaluable by producing novel findings within the current thesis which challenges previous 
observations surrounding sex differences in LD morphology and distribution. As discussed 
previously, the similar inactivity levels of the participants is a novel strength of the current 
study as previous research examined differences between physically active and sedentary 
individuals. The current study also addresses limitations and oversights within the literature 
surrounding participant sex, and age. The novel observations from this thesis suggest that age 
and the influence of sex-hormones might play a key role in differences in LD morphology and 
distribution frequently reported between sexes and metabolic health status.    
Furthermore, the vast majority of research examining differences in IMTG content and lipid 
droplet profile in human skeletal muscle has analysed biopsies obtained from the vastus 
lateralis muscle. However, samples examined in the current study were obtained during 
elective hip arthroplasty surgery, consequently samples were obtained from the gluteus 
maximus muscle which has provided novel findings. The current study also controlled the 
number of fibres analysed ensuring equal analysis of fibre types in both the male and female 
samples. Finally, previous studies that have analysed fibre-type differences have exclusively 
examined the differences between the fibres of men and women (collectively) and not 
specifically the sex differences between fibre-type IMTG content; this is the first study to 
examine sex specific fibre-type differences in LD content.  
Overall, the study presented few limitations, however the limitations that have emerged must 
be addressed. Firstly, it was not possible to investigate fibre type specific LD-mitochondria 
interactions due to limited channels available when using the confocal microscope. However 
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with strong evidence suggesting a positive correlation between both IMTG accumulation-
mitochondrial intensity and IMTG accumulation-mitochondrial function (Moro, Bajpeyi and 
Smith, 2008), future protocols should aim to co-stain bodipy and COX to examine the spatial 
LD-mitochondrial interactions within these groups. Furthermore, the use of COXIV as a marker 
of mitochondrial density presents a limitation in itself. COXIV only labels one specific protein 
within the mitochondria (cytochrome c oxidase) therefore it is a representation of 
mitochondrial content and could underrepresent true mitochondrial density within samples. 
The present study is also potentially limited by not examining deleterious metabolites such as 
DAG and ceramides which have proven to influence insulin action (Amati et al., 2011a). It is 
possible that these metabolites could provide further insight into the mechanisms involved in 
the association of IMTG stores and level of insulin resistance. It is important to recognise that 
the peripheral region defined within this study cannot be directly compared with the 
subsarcolemmal region identified in previous studies using transmission electron microscopy. 
It has been recommended that future research using BOPIDY to detect IMTG should employ a 
smaller peripheral region of 2μm to be more representative of the S.S region (Jevons et al., 
2020). Finally, the limited participant group in this study (older adults) could be extended to 
include younger and/ or age matched controls who are insulin sensitive and have lower HOMA-
IR scores. These control groups would allow a more inclusive representation of the differences 
between LD profile, mitochondrial density and whether these characteristics effect insulin 
action.  
4.7 Future directions for research  
The current thesis is the first to provide an investigation of LD profile within both males and 
females with different metabolic health statuses. Furthermore, the region-specific and fibre-
type differences provide a novel insight into the effects of LD morphology and distribution on 
lipid metabolism and insulin resistance. However, research is still limited surrounding IMTG 
stores in females, specifically within older metabolically impaired females. Therefore, more 
research is required to further develop current understanding of the relationship between 
IMTG and insulin action within these participants.  
Indeed the majority of current research investigating the relationship between IMTG content 
and insulin action has been conducted in cohorts of young males (Shepherd et al., 2017; 
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Daemen, van Polanen and Hesselink, 2018). The limited studies that have investigated both 
males and females do show sex differences in insulin sensitivity and IMTG content (Tarnopolsky 
et al., 2007). However, the current study shows contradictory findings on sex differences in LD 
profile, likely due to the older age of the participants. Therefore, it would be of interest to 
investigate LD morphology and distribution, and mitochondrial density through similar 
immunofluorescent microscopy techniques within similar groups of both young and older 
participants; 1) lean sedentary 2) obese sedentary 3) obese T2D 4) lean active individuals, and 
5) highly trained athletes. This would provide a systematic evaluation of sex and health 
differences in IMTG content and insulin sensitivity. Furthermore, the use of 
immunofluorescence microscopy methods within these groups may highlight important 
differences in LD profile which have previously been overlooked in studies that use whole 
muscle homogenate-based analysis techniques. The subcellular distribution and morphology 
of LD are seen as strong predictors of insulin resistance in human skeletal muscle (Bergman et 
al., 2012), therefore such data would prove invaluable in the understanding of LD influence on 
insulin action.  
Future research should also aim to investigate LD-mitochondria interactions within the groups 
suggested previously; 1) lean sedentary 2) obese sedentary 3) obese T2D 4) lean active 
individuals, and 5) highly trained athletes. It is proposed that these interactions are essential 
in the mechanism that permits a greater rate of IMTG oxidation frequently observed in trained 
athletes resulting in reduced FA levels within their muscle. It is believed that these interactions 
are one of the important metabolic adaptations in trained individuals who have high IMTG 
content yet remain highly insulin sensitive (Goodpaster et al., 2001; van Loon et al., 2004). 
Although mitochondrial density did not differ between males and females nor health groups 
within the current study, assessing the LD-mitochondria interactions could have provided an 
insight into the mechanisms underpinning the LD accumulation in the males and their lower 
HOMA-IR scores compared to the females.  
It is also increasingly believed that DAG and ceramides are the lipotoxic metabolites involved 
in the underlying relationship between IMTG content and insulin resistance (Amati et al., 
2011a; Gemmink et al., 2017), thus supporting the athlete’s paradox and the origin of skeletal 
muscle insulin resistance. However, research investigating these deleterious metabolites in 
human skeletal muscle is indeed limited and proven inconsistent (Straczkowski et al., 2007; 
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Moro et al., 2009; Amati et al., 2011a; Gemmink et al., 2017). The majority of research that 
does support the hypothesis that DAG and ceramides are associated with insulin resistance in 
obese, ageing and T2D individuals is predominantly from rodent models (Chavez et al., 2003; 
Erion and Shulman, 2010; Chavez and Summers, 2012). Therefore, future research needs to 
focus on the link between these deleterious lipid species and skeletal muscle insulin resistance 
within various health groups and both sexes remains to be examined.  
 
Future research should also focus on proteins that reportedly regulate lipid metabolism in 
human skeletal muscle, through examining the direct effect of PLIN expression and LD content 
on insulin action. PLIN5  is expressed in metabolically active tissues (e.g. skeletal muscle), 
where it is suggested to be involved in the regulation of lipolysis and therefore directly affects 
LD size (Gemmink et al., 2016). Research that has previously used rodent models suggested 
that an increased PLIN5 expression is linked to an increase in LD content whilst insulin-
mediated glucose uptake was not impaired (Bosma et al., 2013). Furthermore, complete 
removal of PLIN5 expression in mice resulted in impaired insulin-mediated glucose uptake 
(Mason et al., 2014). Recent research suggests potential involvement of PLIN5 in HSL 
recruitment to LDs, thus potentially augmenting IMTG utilisation (Whytock, 2019). It is also 
believed that PLIN2 is involved in the retention of TAG within LD and the prevention of impaired 
insulin sensitivity induced through high-fat-diets, furthermore PLIN3 expression has also been 
associated with fat oxidation. In human skeletal muscle it had been observed that both PLIN2 
and PLIN3 prove favourable in the reduction of lipid metabolite accumulation (Whytock, 2019; 
Whytock et al., 2020). Therefore, it would be of interest to investigate the expression of these 
proteins within various populations (e.g. male vs female and various metabolic health status’) 
to examine differences in expression and establish a stronger link between lipid metabolism 
and insulin sensitivity. 
4.8 Conclusion  
This thesis has produced novel data on sex and health specific differences in LD morphology 
and distribution. In contrast to our hypothesis and previous literature which reports greater LD 
stores in females, the study demonstrates that males have more LD than females. However, 
the participants in this study were older and the females were postmenopausal; therefore our 
results may in part be explained by the reduced oestrogen concentrations that occur at this 
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time. The increased LD content specifically in type IIa fibres of T2D may suggest a dysregulation 
of LD turnover (synthesis and lipolysis) which is supported by the lower mitochondria content 
in these fibres. The current study provides an initial insight into sex differences in LD 
distribution in older populations and provides a foundation for future research examining 
possible factors which contribute to augmented LD stores and changes in insulin sensitivity. 
Ultimately, the methods and results from the current thesis will assist future research 
hypotheses and investigation on human skeletal muscle lipid metabolism.  
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